Detailed review of transgenic rodent mutation assays

Mutation Research - Reviews in Mutation Research

Volumn 590, Issue 1-3, 2005, Pages 1-280

  Lambert, Iain B ^a,b   Singer, Timothy M ^a   Boucher, Sherri E ^a   Douglas, George R ^a  

^a Environmental Health Center   (Canada)

^b CARLETON UNIVERSITY   (Canada)

Author keywords

Big Blue ; Chemical carcinogenesis; Genetic toxicology; gpt; lacI; lacZ; Lambda; Muta mouse; Mutagenesis; Mutation assay; OECD; spi; Transgenic rodent

Indexed keywords

AMINO ACID; AZATHIOPRINE; CARCINOGEN; CHLORAMBUCIL; CISPLATIN; CLASTOGEN; CYCLOPHOSPHAMIDE; CYPROTERONE ACETATE; DNA; ETOPOSIDE; GENOMIC DNA; HYDRAZINE SULFATE; HYDROXYUREA; LEVOFLOXACIN; METRONIDAZOLE; MITOMYCIN C; MUTAGENIC AGENT; OXAZEPAM; PHENOBARBITAL; PROCARBAZINE; PROPIOLACTONE; QUINOLINE; RACHELMYCIN; TAMOXIFEN; THIOTEPA; TOREMIFENE;

AMINO ACID SUBSTITUTION; BACTERIOPHAGE; BLADDER CARCINOGENESIS; BREAST CARCINOGENESIS; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; CHROMATID EXCHANGE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COLON CARCINOGENESIS; DNA DAMAGE; DNA DEGRADATION; DNA ISOLATION; DNA METABOLISM; DNA REPAIR; DNA REPLICATION; DNA SEQUENCE; DNA STRAND BREAKAGE; DNA SYNTHESIS; ENVIRONMENTAL EXPOSURE; EXCISION REPAIR; GENE LOCUS; GENE MUTATION; GENETIC TOXICOLOGY; GENOME ANALYSIS; GENOTOXICITY; GERM CELL; HEMATOPOIETIC CELL; HETEROZYGOSITY; HOMOZYGOSITY; INDUCED MUTATION; LACTOSE OPERON; LIVER CARCINOGENESIS; LUNG CARCINOGENESIS; MAXIMUM TOLERATED DOSE; MITOCHONDRIAL DNA DEPLETION; MOLECULAR CLONING; MOUSE STRAIN; MUTAGENICITY; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RADIATION MUTAGENESIS; REVIEW; SEQUENCE ANALYSIS; SHUTTLE VECTOR; SOMATIC MUTATION; SPECIES COMPARISON; SPONTANEOUS MUTATION; STOMACH CARCINOGENESIS; TISSUE SPECIFICITY; TRANSGENE; TRANSGENIC ANIMAL; TRANSGENIC MOUSE; X IRRADIATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; MICE; MUTAGENESIS; MUTAGENS; RODENTIA;

ANIMALIA; RODENTIA;

EID: 23744463885     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2005.04.002     Document Type: Review

References (474)

1. I.M. Jones, K. Burkhart-Schultz, and A.V. Carrano A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes Mutat. Res. 147 1985 97 105
2. D.J. Winton, M.A. Blount, and B.A. Ponder A clonal marker induced by mutation in mouse intestinal epithelium Nature 333 1988 463 466
3. A. Aidoo, L.E. Lyn-Cook, R.A. Mittelstaedt, R.H. Heflich, and D.A. Casciano Induction of 6-thioguanine-resistant lymphocytes in Fischer 344 rats following in vivo exposure to N-ethyl-N-nitrosourea and cyclophosphamide Environ. Mol. Mutagen. 17 1991 141 151
4. P.B. McKinzie, and B.L. Parsons Detection of rare K-ras codon 12 mutations using allele-specific competitive blocker PCR Mutat. Res. 517 2002 209 220
5. P.B. McKinzie, R.R. Delongchamp, R.H. Heflich, and B.L. Parsons Prospects for applying genotypic selection of somatic oncomutation to chemical risk assessment Mutat. Res. 489 2001 47 78
6. B.L. Parsons, and R.H. Heflich Detection of a mouse H-ras codon 61 mutation using a modified allele-specific competitive blocker PCR genotypic selection method Mutagenesis 13 1998 581 588
7. B.L. Parsons, and R.H. Heflich Detection of basepair substitution mutation at a frequency of 1 × 10(-7) by combining two genotypic selection methods, MutEx enrichment and allele-specific competitive blocker PCR Environ. Mol. Mutagen. 32 1998 200 211
8. B.L. Parsons, and R.H. Heflich Genotypic selection methods for the direct analysis of point mutations Mutat. Res. 387 1997 97 121
9. J. Ashby, and H. Tinwell Use of transgenic mouse lacI/Z mutation assays in genetic toxicology Mutagenesis 9 1994 179 181
10. J. Ashby, N.J. Gorelick, and M.D. Shelby Mutation assays in male germ cells from transgenic mice: overview of study and conclusions Mutat. Res. 388 1997 111 122
11. M.L. Cunningham, and H.B. Matthews Cell proliferation as a determining factor for the carcinogenicity of chemicals: studies with mutagenic carcinogens and mutagenic noncarcinogens Toxicol. Lett. 82-83 1995 9 14
12. S.W. Dean, T.M. Brooks, B. Burlinson, J. Mirsalis, B. Myhr, L. Recio, and V. Thybaud Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens Mutagenesis 14 1999 141 151
13. M.J. Dycaico, G.S. Provost, P.L. Kretz, S.L. Ransom, J.C. Moores, and J.M. Short The use of shuttle vectors for mutation analysis in transgenic mice and rats Mutat. Res. 307 1994 461 478
14. T.L. Goldsworthy, L. Recio, K. Brown, L.A. Donehower, J.C. Mirsalis, R.W. Tennant, and I.F. Purchase Transgenic animals in toxicology Fundam. Appl. Toxicol. 22 1994 8 19
15. N.J. Gorelick, and E.D. Thompson Overview of the workshops on statistical analysis of mutation data from transgenic mice Environ. Mol. Mutagen. 23 1994 12 16
16. N.J. Gorelick Overview of mutation assays in transgenic mice for routine testing Environ. Mol. Mutagen. 25 1995 218 230
17. N.J. Gorelick Validation issues for the use of transgenic mouse mutation assays in risk assessment Prog. Clin. Biol. Res. 395 1996 81 108
18. J.A. Gossen, W.J. de Leeuw, and J. Vijg LacZ transgenic mouse models: their application in genetic toxicology Mutat. Res. 307 1994 451 459
19. H.J. Martus, M.E. Dolle, J.A. Gossen, M.E. Boerrigter, and J. Vijg Use of transgenic mouse models for studying somatic mutations in aging Mutat. Res. 338 1995 203 213
20. J.C. Mirsalis, J.A. Monforte, and R.A. Winegar Transgenic animal models for measuring mutations in vivo Crit. Rev. Toxicol. 24 1994 255 280
21. J.C. Mirsalis, J.A. Monforte, and R.A. Winegar Transgenic animal models for detection of in vivo mutations Annu. Rev. Pharmacol. Toxicol. 35 1995 145 164
22. V. Morrison, and J. Ashby A preliminary evaluation of the performance of the Muta™Mouse (lacZ) and Big Blue (lacI) transgenic mouse mutation assays Mutagenesis 9 1994 367 375
23. M. Nagao A new approach to risk estimation of food-borne carcinogens - heterocyclic amines - based on molecular information Mutat. Res. 431 1999 3 12
24. T. Nohmi, T. Suzuki, and K. Masumura Recent advances in the protocols of transgenic mouse mutation assays (In Process Citation) Mutat. Res. 455 2000 191 215
25. G.S. Provost, P.L. Kretz, R.T. Hamner, C.D. Matthews, B.J. Rogers, K.S. Lundberg, M.J. Dycaico, and J.M. Short Transgenic systems for in vivo mutation analysis (see comments) Mutat. Res. 288 1993 133 149
26. P. Schmezer, C. Eckert, U.M. Liegibel, R.G. Klein, and H. Bartsch Use of transgenic mutational test systems in risk assessment of carcinogens Arch. Toxicol. Suppl 20 1998 321 330
27. P. Schmezer, C. Eckert, U.M. Liegibel, O. Zelezny, and R.G. Klein Mutagenic activity of carcinogens detected in transgenic rodent mutagenicity assays at dose levels used in chronic rodent cancer bioassays Mutat. Res. 405 1998 193 198
28. ® and Muta™ mouse IARC Sci. Publ. 1999 367 394
29. S.E. Shephard, W.K. Lutz, and C. Schlatter The lacI transgenic mouse mutagenicity assay: quantitative evaluation in comparison to tests for carcinogenicity and cytogenetic damage in vivo Mutat. Res. 306 1994 119 128
30. G.R. Stuart, and B.W. Glickman Through a glass, darkly: reflections of mutation from lacI transgenic mice Genetics 155 2000 1359 1367
31. T. Suzuki, S. Itoh, M. Nakajima, N. Hachiya, and T. Hara Target organ and time-course in the mutagenicity of five carcinogens in Muta™ mouse: a summary report of the second collaborative study of the transgenic mouse mutation assay by JEMS/MMS Mutat. Res. 444 1999 259 268
32. J. Vijg, M.E. Dolle, H.J. Martus, and M.E. Boerrigter Transgenic mouse models for studying mutations in vivo: applications in aging research (corrected and republished article originally printed in Mech Ageing Dev 1997 Dec;98(3):189-202) Mech. Ageing Dev. 99 1997 257 271
33. M.I. Willems, J. van Benthem, Mutagenicity of Chemicals in genetically modified animals, RIVM Report no. 650210 002; TNO Report no. V99.1097, Biltoven, National Institute of Public Health and the Environment (RIVM); Netherlands Organization for Applied Scientific Research (TNO), 2000, pp. 1-47.
34. J.A. Gossen, W.J. de Leeuw, C.H. Tan, E.C. Zwarthoff, F. Berends, P.H. Lohman, D.L. Knook, and J. Vijg Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo Proc. Natl. Acad. Sci. U.S.A. 86 1989 7971 7975
35. D.H. Blakey, G.R. Douglas, K.C. Huang, and H.J. Winter Cytogenetic mapping of lambda gt10 lacZ sequences in the transgenic mouse strain 40.6 (Muta™ mouse) Mutagenesis 10 1995 145 148
36. J.A. Gossen, W.J. de Leeuw, A. Verwest, P.H. Lohman, and J. Vijg High somatic mutation frequencies in a LacZ transgene integrated on the mouse X-chromosome Mutat. Res. 250 1991 423 429
37. J. Vijg, and G.R. Douglas G. Pfeifer Bacteriophage lambda and plasmid lacZ transgenic mice for studying mutations in vivo 1996 Plenum Press New York 391 410
38. S.W. Kohler, G.S. Provost, P.L. Kretz, A. Fieck, J.A. Sorge, and J.M. Short The use of transgenic mice for short-term, in vivo mutagenicity testing Genet. Anal. Tech. Appl. 7 1990 212 218
39. S.W. Kohler, G.S. Provost, A. Fieck, P.L. Kretz, W.O. Bullock, J.A. Sorge, D.L. Putman, and J.M. Short Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice Proc. Natl. Acad. Sci. U.S.A. 88 1991 7958 7962
40. S.W. Kohler, G.S. Provost, A. Fieck, P.L. Kretz, W.O. Bullock, D.L. Putman, J.A. Sorge, and J.M. Short Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector Environ. Mol. Mutagen. 18 1991 316 321
41. J.A. Gossen, H.J. Martus, J.Y. Wei, and J. Vijg Spontaneous and X-ray-induced deletion mutations in a LacZ plasmid- based transgenic mouse model Mutat. Res. 331 1995 89 97
42. J.A. Gossen, W.J. de Leeuw, A.C. Molijn, and J. Vijg Plasmid rescue from transgenic mouse DNA using LacI repressor protein conjugated to magnetic beads Biotechniques 14 1993 624 629
43. M.E. Dolle, H.J. Martus, J.A. Gossen, M.E. Boerrigter, and J. Vijg Evaluation of a plasmid-based transgenic mouse model for detecting in vivo mutations Mutagenesis 11 1996 111 118
44. M.E. Dolle, W.K. Snyder, N.J. van Orsouw, and J. Vijg Background mutations and polymorphisms in LacZ-plasmid transgenic mice Environ. Mol. Mutagen. 34 1999 112 120
45. T. Nohmi, M. Katoh, H. Suzuki, M. Matsui, M. Yamada, M. Watanabe, M. Suzuki, N. Horiya, O. Ueda, T. Shibuya, H. Ikeda, and T. Sofuni A new transgenic mouse mutagenesis test system using spi- and 6-thioguanine selections Environ. Mol. Mutagen. 28 1996 465 470
46. K. Masumura, M. Matsui, M. Katoh, N. Horiya, O. Ueda, H. Tanabe, M. Yamada, H. Suzuki, T. Sofuni, and T. Nohmi Spectra of gpt mutations in ethylnitrosourea-treated and untreated transgenic mice Environ. Mol. Mutagen. 34 1999 1 8
47. - selection Environ. Mol. Mutagen. 41 2003 253 259
48. T. Nohmi, M. Suzuki, K. Masumura, M. Yamada, K. Matsui, O. Ueda, H. Suzuki, M. Katoh, H. Ikeda, and T. Sofuni spi(-) selection: an efficient method to detect gamma-ray-induced deletions in transgenic mice Environ. Mol. Mutagen. 34 1999 9 15
49. - assay for mutations in gpt delta mice by including magnesium ions during plaque formation Environ. Mol. Mutagen. 41 2003 370 372
50. J.L. Jakubczak, G. Merlino, J.E. French, W.J. Muller, B. Paul, S. Adhya, and S. Garges Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target Proc. Natl. Acad. Sci. U.S.A. 93 1996 9073 9078
51. E.G. Leach, E.J. Gunther, T.M. Yeasky, L.H. Gibson, T.L. Yang-Feng, and P.M. Glazer Frequent spontaneous deletions at a shuttle vector locus in transgenic mice Mutagenesis 11 1996 49 56
52. E.G. Leach, L. Narayanan, P.A. Havre, E.J. Gunther, T.M. Yeasky, and P.M. Glazer Tissue specificity of spontaneous point mutations in lambda supF transgenic mice Environ. Mol. Mutagen. 28 1996 459 464
53. S.E. Andrew, S. Pownall, J. Fox, L. Hsiao, J. Hambleton, J.E. Penney, S.W. Kohler, and F.R. Jirik A novel lacI transgenic mutation-detection system and its application to establish baseline mutation frequencies in the scid mouse Mutat. Res. 357 1996 57 66
54. Y. Gondo, Y. Shioyama, K. Nakao, and M. Katsuki A novel positive detection system of in vivo mutations in rpsL (strA) transgenic mice Mutat. Res. 360 1996 1 14
55. H.V. Malling, and R.R. Delongchamp Direct separation of in vivo and in vitro am3 revertants in transgenic mice carrying the phiX174 am3, cs70 vector Environ. Mol. Mutagen. 37 2001 345 355
56. C.R. Valentine, J.L. Raney, J.G. Shaddock, V.N. Dobrovolsky, and R.R. Delongchamp In vivo mutation in gene A of splenic lymphocytes from PhiX174 transgenic mice Environ. Mol. Mutagen. 44 2004 128 150
57. J.A. Gossen, and J. Vijg A selective system for lacZ- phage using a galactose-sensitive E. coli host Biotechniques 14 1993 326 330
58. G.R. Douglas, J.D. Gingerich, J.A. Gossen, and S.A. Bartlett Sequence spectra of spontaneous lacZ gene mutations in transgenic mouse somatic and germline tissues Mutagenesis 9 1994 451 458
59. K.A. Hill, V.L. Buettner, A. Halangoda, M. Kunishige, S.R. Moore, J. Longmate, W.A. Scaringe, and S.S. Sommer Spontaneous mutation in Big Blue mice from fetus to old age: tissue-specific time courses of mutation frequency but similar mutation types Environ. Mol. Mutagen. 43 2004 110 120
60. H. Nishino, D.J. Schaid, V.L. Buettner, J. Haavik, and S.S. Sommer Mutation frequencies but not mutant frequencies in Big Blue mice fit a Poisson distribution Environ. Mol. Mutagen. 28 1996 414 417
61. K.S. Tao, C. Urlando, and J.A. Heddle Comparison of somatic mutation in a transgenic versus host locus Proc. Natl. Acad. Sci. U.S.A. 90 1993 10681 10685
62. S.J. Culp, F.A. Beland, R.H. Heflich, R.W. Benson, L.R. Blankenship, P.J. Webb, P.W. Mellick, R.W. Trotter, S.D. Shelton, K.J. Greenlees, and M.G. Manjanatha Mutagenicity and carcinogenicity in relation to DNA adduct formation in rats fed leucomalachite green Mutat. Res. 506-507 2002 55 63
63. B.S. Shane, J.G. deBoer, B.W. Glickman, and M.L. Cunningham Oxazepam is mutagenic in vivo in Big Blue transgenic mice Carcinogenesis 20 1999 1315 1321
64. B.S. Shane, D.L. Smith-Dunn, J.G. deBoer, B.W. Glickman, and M.L. Cunningham Subchronic administration of phenobarbital alters the mutation spectrum of lacI in the livers of Big Blue transgenic mice Mutat. Res. 448 2000 69 80
65. V.K. Singh, L. Ganesh, M.L. Cunningham, and B.S. Shane Comparison of the mutant frequencies and mutation spectra of three non-genotoxic carcinogens, oxazepam, phenobarbital, and Wyeth 14,643, at the λcII locus in Big Blue transgenic mice Biochem. Pharmacol. 62 2001 685 692
66. L. Cosentino, and J.A. Heddle A test for neutrality of mutations of the lacZ transgene Environ. Mol. Mutagen. 28 1996 313 316
67. R.R. Swiger, L. Cosentino, N. Shima, J.H. Bielas, W. Cruz-Munoz, and J.A. Heddle The cII locus in the Muta™ mouse system Environ. Mol. Mutagen. 34 1999 201 207
68. R.R. Swiger, L. Cosentino, K.I. Masumura, T. Nohmi, and J.A. Heddle Further characterization and validation of gpt delta transgenic mice for quantifying somatic mutations in vivo Environ. Mol. Mutagen. 37 2001 297 303
69. J.A. Heddle, H.J. Martus, and G.R. Douglas Treatment and sampling protocols for transgenic mutation assays Environ. Mol. Mutagen. 41 2003 1 6
70. The Collaborative Study Group for the Transgenic Mouse Mutation Assay Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan, Organ variation in the mutagenicity of ethylnitrosourea in Muta™ mouse: results of the collaborative study on the transgenic mutation assay by JEMS/MMS, Environ. Mol. Mutagen., 28 (1996) 363-375.
71. T. Itoh1, T. Suzuki, A. Nishikawa, F. Furukawa, M. Takahashi, W. Xue, T. Sofuni, and M. Hayashi In vivo genotoxicity of 2-amino-3,8-dimethylimidazo[4,5- f]quinoxaline in lacI transgenic (Big Blue) mice Mutat. Res. 468 2000 19 25
72. S. Itoh, M. Miura, T. Itoh, Y. Miyauchi, M. Suga, Y. Takahashi, Y. Kasahara, E. Yamamura, H. Hirono, and H. Shimada N-Nitrosodi-N-propylamine induces organ specific mutagenesis with specific expression times in lacZ transgenic mice Mutat. Res. 444 1999 309 319
73. A. Nishikawa, F. Furukawa, K. Kasahara, S. Ikezaki, T. Itoh, T. Suzuki, K. Uchida, M. Kurihara, M. Hayashi, N. Miyata, and M. Hirose Trans-4-hydroxy-2-nonenal, an aldehydic lipid peroxidation product, lacks genotoxicity in lacI transgenic mice Cancer Lett. 148 2000 81 86
74. Y. Noda, T. Suzuki, A. Kohara, A. Hasegawa, T. Yotsuyanagi, M. Hayashi, T. Sofuni, K. Yamanaka, and S. Okada In vivo genotoxicity evaluation of dimethylarsinic acid in Muta™ mouse Mutat. Res. 513 2002 205 212
75. M.G. Manjanatha, S.D. Shelton, M. Bishop, J.G. Shaddock, V.N. Dobrovolsky, R.H. Heflich, P.J. Webb, L.R. Blankenship, F.A. Beland, K.J. Greenlees, and S.J. Culp Analysis of mutations and bone marrow micronuclei in Big Blue rats fed leucomalachite green Mutat. Res. 547 2004 5 18
76. G.L. Erexson, M.L. Cunningham, and K.R. Tindall Cytogenetic characterization of the transgenic Big Blue Rat2 and Big Blue mouse embryonic fibroblast cell lines Mutagenesis 13 1998 649 653
77. ® mouse and rat primary fibroblast cell strains for use in molecular toxicology studies Environ. Mol. Mutagen. 34 1999 90 96
78. S.R. Gonda, H. Wu, P.L. Pingerelli, and B.W. Glickman Three-dimensional transgenic cell model to quantify genotoxic effects of space environment Adv. Space Res. 27 2001 421 430
79. ® rat: an in vitro mutagenesis assay Mutat. Res. 497 2001 39 47
80. H.M. McDiarmid, G.R. Douglas, B.L. Coomber, and P.D. Josephy 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mutagenesis in cultured Big Blue rat mammary epithelial and fibroblast cells Environ. Mol. Mutagen. 39 2002 245 253
81. J. Ryu, J. Youn, Y. Kim, O. Kwon, Y. Song, H. Kim, K. Cho, and I. Chang Mutation spectrum of 4-nitroquinoline N-oxide in the lacI transgenic Big Blue Rat2 cell line Mutat. Res. 445 1999 127 135
82. J.C. Ryu, Y.J. Kim, and Y.G. Chai Mutation spectrum of 1,2-dibromo-3-chloropropane, an endocrine disruptor, in the lacI transgenic Big Blue Rat2 fibroblast cell line Mutagenesis 17 2002 301 307
83. C.J. Saranko, and L. Recio The butadiene metabolite 1,2,3,4- diepoxybutane, induces micronuclei but is only weakly mutagenic at lacI in the Big Blue Rat2 lacI transgenic cell line Environ. Mol. Mutagen. 31 1998 32 40
84. A. Suri, J. deBoer, W. Kusser, and B.W. Glickman A 3 milliTesla 60 Hz magnetic field is neither mutagenic nor co-mutagenic in the presence of menadione and MNU in a transgenic rat cell line Mutat. Res. 372 1996 23 31
85. P.A. White, G.R. Douglas, J. Gingerich, C. Parfett, P. Shwed, V. Seligy, L. Soper, L. Berndt, J. Bayley, S. Wagner, K. Pound, and D. Blakey Development and characterization of a stable epithelial cell line from Muta™ mouse lung Environ. Mol. Mutagen. 42 2003 166 184
86. D.L. Wyborski, S. Malkhosyan, J. Moores, M. Perucho, and J.M. Short Development of a rat cell line containing stably integrated copies of a lambda/lacI shuttle vector Mutat. Res. 334 1995 161 165
87. M.W. Lieberman, R.M. Lebovitz, Neoplasia, in: I. Damajanov, J. Linder (Eds.), Mosby Year Book, St. Louis, 1996, pp. 513-547.
88. OECD, Test Guideline 473: in vitro mammalian chromosome aberration test, in: OECD Guidelines for Testing of Chemicals, Organization for Economic Cooperation and Development, Paris, 1997.
89. M. Kirsch-Volders, T. Sofuni, M. Aardema, S. Albertini, D. Eastmond, M. Fenech, M. Ishidate, E. Lorge, H. Norppa, J. Surralles, W. von der Hude, and A. Wakata Report from the in vitro micronucleus assay working group Environ. Mol. Mutagen. 35 2000 167 172
90. M. Kirsch-Volders, T. Sofuni, M. Aardema, S. Albertini, D. Eastmond, M. Fenech, M. Ishidate, S. Kirchner, E. Lorge, T. Morita, H. Norppa, J. Surralles, A. Vanhauwaert, and A. Wakata Report from the in vitro micronucleus assay working group Mutat. Res. 540 2003 153 163
91. OECD, Test Guideline 471: bacterial reverse mutation test, in: OECD Guidelines for Testing of Chemicals, Organization for Economic Cooperation and Development, Paris, 1997.
92. OECD, Guideline 476: in vitro mammalian cell gene mutation test, in: OECD Guidelines for Testing of Chemicals, Organization for Economic Cooperation and Development, Paris, 1997.
93. OECD, Test Guideline 474: mammalian erythrocyte micronucleus test, in: OECD Guidelines for Testing of Chemicals, Organization for Economic Cooperation and Development, Paris, 1997.
94. J.A. Heddle, M.C. Cimino, M. Hayashi, F. Romagna, M.D. Shelby, J.D. Tucker, P. Vanparys, and J.T. MacGregor Micronuclei as an index of cytogenetic damage: past, present, and future Environ. Mol. Mutagen. 18 1991 277 291
95. K.H. Mavournin, D.H. Blakey, M.C. Cimino, M.F. Salamone, and J.A. Heddle The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the US, Environmental Protection Agency Gene-Tox Program Mutat. Res. 239 1990 29 80
96. G. Krishna, and M. Hayashi In vivo rodent micronucleus assay: protocol, conduct and data interpretation Mutat. Res. 455 2000 155 166
97. M.F. Salamone, and K.H. Mavournin Bone marrow micronucleus assay: a review of the mouse stocks used and their published mean spontaneous micronucleus frequencies Environ. Mol. Mutagen. 23 1994 239 273
98. M.D. Waters, H.F. Stack, M.A. Jackson, B.A. Bridges, and I.D. Adler The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis Mutat. Res. 341 1994 109 131
99. K.L. Witt, L.A. Hughes, L.T. Burka, A.F. McFee, J.M. Mathews, S.L. Black, and J.B. Bishop Mouse bone marrow micronucleus test results do not predict the germ cell mutagenicity of N-hydroxymethylacrylamide in the mouse dominant lethal assay Environ. Mol. Mutagen. 41 2003 111 120
100. OECD, Test Guideline 475: mammalian bone marrow chromosomal aberration test, in: OECD Guidelines for Testing of Chemicals, Organization for Economic Cooperation and Development, Paris, 1997.
101. OECD, Test Guideline 484: mouse spot test, in: OECD Guidelines for Testing of Chemicals, Organization for Economic Cooperation and Development, Paris, 1986.
102. L.B. Russell, and M.H. Major Radiation-induced presumed somatic mutations in the house mouse Genetics 42 1957 161 175
103. R. Fahrig A mammalian spot test: induction of genetic alterations in pigment cells of mouse embryos with X-rays and chemical mutagens Mol. Gen. Genet. 138 1975 309 314
104. L.B. Russell Validation of the in vivo somatic mutation method in the mouse as a prescreen for germinal point mutations Arch. Toxicol. 38 1977 75 85
105. R. Fahrig The mouse spot test D.H. Phillips S. Venitt Environmental Mutagenesis 1995 Bios Scientific Publishers Oxford 180 199
106. R. Fahrig, and A. Neuhauser-Klaus Similar pigmentation characteristics in the specific-locus and the mammalian spot test. A way to distinguish between induced mutation and recombination J. Hered. 76 1985 421 426
107. Y. Gondo, J.M. Gardner, Y. Nakatsu, D. Durham-Pierre, S.A. Deveau, C. Kuper, and M.H. Brilliant High-frequency genetic reversion mediated by a DNA duplication: the mouse pink-eyed unstable mutation Proc. Natl. Acad. Sci. U.S.A. 90 1993 297 301
108. A.G. Searle The use of pigment loci for detecting reverse mutations in somatic cells of mice Arch. Toxicol. 38 1977 105 108
109. R. Reliene, A.J. Bishop, J. Aubrecht, and R.H. Schiestl In vivo DNA deletion assay to detect environmental and genetic predisposition to cancer Methods Mol. Biol. 262 2004 125 139
110. R.H. Schiestl, J. Aubrecht, F. Khogali, and N. Carls Carcinogens induce reversion of the mouse pink-eyed unstable mutation Proc. Natl. Acad. Sci. U.S.A. 94 1997 4576 4581
111. R.H. Schiestl, J. Aubrecht, W.Y. Yap, S. Kandikonda, and S. Sidhom Polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin induce intrachromosomal recombination in vitro and in vivo Cancer Res. 57 1997 4378 4383
112. T. Jalili, G.G. Murthy, and R.H. Schiestl Cigarette smoke induces DNA deletions in the mouse embryo Cancer Res. 58 1998 2633 2638
113. A.J. Bishop, B. Kosaras, R.L. Sidman, and R.H. Schiestl Benzo[a]pyrene and X-rays induce reversions of the pink-eyed unstable mutation in the retinal pigment epithelium of mice Mutat. Res. 457 2000 31 40
114. L. Bodenstein, and R.L. Sidman Growth and development of the mouse retinal pigment epithelium. I. Cell and tissue morphometrics and topography of mitotic activity Dev. Biol. 121 1987 192 204
115. A.D. Tates, F.J. van Dam, F.A. de Zwart, C.M. van Teylingen, and A.T. Natarajan Development of a cloning assay with high cloning efficiency to detect induction of 6-thioguanine-resistant lymphocytes in spleen of adult mice following in vivo inhalation exposure to 1,3-butadiene Mutat. Res. 309 1994 299 306
116. P.P. Van Sloun, S.W. Wijnhoven, H.J. Kool, R. Slater, G. Weeda, A.A. van Zeeland, P.H. Lohman, and H. Vrieling Determination of spontaneous loss of heterozygosity mutations in Aprt heterozygous mice Nucleic Acids Res. 26 1998 4888 4894
117. L. Lommel, C. Carswell-Crumpton, and P.C. Hanawalt Preferential repair of the transcribed DNA strand in the dihydrofolate reductase gene throughout the cell cycle in UV-irradiated human cells Mutat. Res. 336 1995 181 192
118. V.N. Dobrovolsky, T. Chen, and R.H. Heflich Molecular analysis of in vivo mutations induced by N-ethyl-N-nitrosourea in the autosomal Tk and the X-linked Hprt genes of mouse lymphocytes Environ. Mol. Mutagen. 34 1999 30 38
119. +/- heterozygous mouse Mutat. Res. 351 1996 67 77
120. V.E. Walker, I.M. Jones, T.L. Crippen, Q. Meng, D.M. Walker, M.J. Bauer, A.A. Reilly, A.D. Tates, J. Nakamura, P.B. Upton, and T.R. Skopek Relationships between exposure, cell loss and proliferation, and manifestation of Hprt mutant T cells following treatment of preweanling, weanling, and adult male mice with N-ethyl-N-nitrosourea Mutat. Res. 431 1999 371 388
121. M.K. Dush, J.A. Tischfield, S.A. Khan, E. Feliciano, J.M. Sikela, C.A. Kozak, and P.J. Stambrook An unusual adenine phosphoribosyltransferase pseudogene is syntenic with its functional gene and is flanked by highly polymorphic DNAs Mol. Cell. Biol. 6 1986 4161 4167
122. A. Fratini, R.N. Simmers, D.F. Callen, V.J. Hyland, J.A. Tischfield, P.J. Stambrook, and G.R. Sutherland A new location for the human adenine phosphoribosyltransferase gene (APRT) distal to the haptoglobin (HP) and fra(16)(q23)(FRA16D) loci Cytogenet. Cell. Genet. 43 1986 10 13
123. J.A. Tischfield Loss of heterozygosity or: how I learned to stop worrying and love mitotic recombination Am. J. Hum. Genet. 61 1997 995 999
124. C. Shao, L. Deng, O. Henegariu, L. Liang, N. Raikwar, A. Sahota, P.J. Stambrook, and J.A. Tischfield Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice Proc. Natl. Acad. Sci. U.S.A. 96 1999 9230 9235
125. O.N. Ponomareva, J.A. Rose, M. Lasarev, J. Rasey, and M.S. Turker Tissue-specific deletion and discontinuous loss of heterozygosity are signatures for the mutagenic effects of ionizing radiation in solid tissues Cancer Res. 62 2002 1518 1523
126. P.J. Stambrook, C. Shao, M. Stockelman, G. Boivin, S.J. Engle, and J.A. Tischfield APRT: a versatile in vivo resident reporter of local mutation and loss of heterozygosity Environ. Mol. Mutagen. 28 1996 471 482
127. +/- mouse model for detecting in vivo mutation in an endogenous, autosomal gene Mutat. Res. 423 1999 125 136
128. +/- embryonic stem cell line for use in mutagenicity studies Environ. Mol. Mutagen. 28 1996 483 489
129. J. Hozier, J. Scalzi, J. Sawyer, N. Carley, M. Applegate, D. Clive, and M.M. Moore Localization of the mouse thymidine kinase gene to the distal portion of chromosome 11 Genomics 10 1991 827 830
130. V.N. Dobrovolsky, J.G. Shaddock, and R.H. Heflich 7,12-Dimethylbenz[a] anthracene-induced mutation in the Tk gene of Tk(+/-) mice: automated scoring of lymphocyte clones using a fluorescent viability indicator Environ. Mol. Mutagen. 36 2000 283 291
131. V.N. Dobrovolsky, J.G. Shaddock, and R.H. Heflich Mutagenicity of gamma-radiation, mitomycin C, and etoposide in the Hprt and Tk genes of Tk(+/-) mice Environ. Mol. Mutagen. 39 2002 342 347
132. +/- mouse lymphoma cells at varying times post-treatment Environ. Mutagen. 4 1982 499 519
133. D.J. Winton, N.J. Gooderham, A.R. Boobis, D.S. Davies, and B.A. Ponder Mutagenesis of mouse intestine in vivo using the Dlb-1 specific locus test: studies with 1,2-dimethylhydrazine, dimethylnitrosamine, and the dietary mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline Cancer Res. 50 1990 7992 7996
134. H.G. Uiterdijk, B.A. Ponder, M.F. Festing, J. Hilgers, L. Skow, and R. Van Nie The gene controlling the binding sites of Dolichos biflorus agglutinin, Dlb-1, is on chromosome 11 of the mouse Genet. Res. 47 1986 125 129
135. OECD, Test Guideline 479: in vitro sister chromatid exchange assay in mammalian cells, in: OECD Guidelines for Testing of Chemicals, Organization for Economic Cooperation and Development, Paris, 1986.
136. R. Rodriguez-Reyes, and P. Morales-Ramirez Sister chromatid exchange induction and the course of DNA duplication, two mechanisms of sister chromatid exchange induction by ENU and the role of BrdU Mutagenesis 18 2003 65 72
137. P. Perry, and H.J. Evans Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange Nature 258 1975 121 125
138. OECD, Test Guideline 486: unscheduled DNA synthesis (UDS) test with mammalian liver cells in vitro, in: OECD Guidelines for Testing of Chemicals, Organization for Economic Cooperation and Development, Paris, 1997.
139. S. Madle, S.W. Dean, U. Andrae, G. Brambilla, B. Burlinson, D.J. Doolittle, C. Furihata, T. Hertner, C.A. McQueen, and H. Mori Recommendations for the performance of UDS tests in vitro and in vivo Mutat. Res. 312 1994 263 285
140. G.A. Sega Unscheduled DNA synthesis in the germ cells of male mice exposed in vivo to the chemical mutagen ethyl methanesulfonate Proc. Natl. Acad. Sci. U.S.A. 71 1974 4955 4959
141. G.A. Sega Unscheduled DNA synthesis (DNA repair) in the germ cells of male mice - its role in the study of mammalian mutagenesis Genetics 92 1979 49 58
142. P.K. Working, and B.E. Butterworth An assay to detect chemically induced DNA repair in rat spermatocytes Environ. Mutagen. 6 1984 273 286
143. OECD, Test Guideline 451: carcinogenicity studies, in: OECD Guidelines for Testing of Chemicals, Organization for Economic Cooperation and Development, Paris, 1981.
144. J.A. Heddle, S. Dean, T. Nohmi, M. Boerrigter, D. Casciano, G.R. Douglas, B.W. Glickman, N.J. Gorelick, J.C. Mirsalis, H.J. Martus, T.R. Skopek, V. Thybaud, K.R. Tindall, and N. Yajima In vivo transgenic mutation assays Environ. Mol. Mutagen. 35 2000 253 259
145. V. Thybaud, S. Dean, T. Nohmi, J. deBoer, G.R. Douglas, B.W. Glickman, N.J. Gorelick, J.A. Heddle, R.H. Heflich, I. Lambert, H.J. Martus, J.C. Mirsalis, T. Suzuki, and N. Yajima In vivo transgenic mutation assays Mutat. Res. 540 2003 141 151
146. M.D. Waters, H.F. Stack, N.E. Garrett, and M.A. Jackson The Genetic Activity Profile database Environ. Health Perspect. 96 1991 41 45
147. C.J. Saranko, K.G. Meyer, L.J. Pluta, R.F. Henderson, and L. Recio Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene Mutat. Res. 473 2001 37 49
148. L. Recio, J.A. Bond, L.J. Pluta, and S.C. Sisk Use of transgenic mice for assessing the mutagenicity of 1,3-butadiene in vivo IARC Sci. Publ. 1993 235 243
149. L. Recio, S. Osterman-Golkar, G.A. Csanady, M.J. Turner, B. Myhr, O. Moss, and J.A. Bond Determination of mutagenicity in tissues of transgenic mice following exposure to 1,3-butadiene and N-ethyl-N-nitrosourea Toxicol. Appl. Pharmacol. 117 1992 58 64
150. K. Yamada, T. Suzuki, A. Kohara, M. Hayashi, A. Hakura, T. Mizutani, and K. Saeki Effect of 10-aza-substitution on benzo[a]pyrene mutagenicity in vivo and in vitro Mutat. Res. 521 2002 187 200
151. A.S. Thornton, Y. Oda, G.R. Stuart, B.W. Glickman, and J.G. deBoer Mutagenicity of TCDD in Big Blue transgenic rats Mutat. Res. 478 2001 45 50
152. W. Suter, R. Ahiabor, B. Blanco, F. Locher, F. Mantovani, M. Robinson, G. Sreenan, F. Staedtler, T. Swingler, A. Vignutelli, and E. Perentes Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay Environ. Mol. Mutagen. 28 1996 354 362
153. M.M. von Pressentin, M. Chen, and J.B. Guttenplan Mutagenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-4- (methylnitrosamino)-1-(3- pyridyl)-1-butanone and N-nitrosonornicotine in lacZ upper aerodigestive tissue and liver and inhibition by green tea Carcinogenesis 22 2001 203 206
154. K. Fletcher, H. Tinwell, and J. Ashby Mutagenicity of the human bladder carcinogen 4-aminobiphenyl to the bladder of Muta™ mouse transgenic mice Mutat. Res. 400 1998 245 250
155. S.D. Turner, H. Tinwell, W. Piegorsch, P. Schmezer, and J. Ashby The male rat carcinogens limonene and sodium saccharin are not mutagenic to male Big Blue rats Mutagenesis 16 2001 329 332
156. F. Staedtler, J. Crespo-Perez, P. Sagelsdorff, S. Steiner, and W. Suter 4-Chloro-o-phenylenediamine induces a dose-related increase in G:C > T:A transversions and one major DNA adduct in the liver of Big Blue mice after 26 weeks in feed treatment Mutat. Res. 430 1999 121 130
157. W. Suter, F. Staedtler, F. Poetter-Locher, T. Swingler, and L. Wilson 4-Chloro-o-phenylenediamine: a 26-week oral (in feed) mutagenicity study in Big Blue mice Mutat. Res. 414 1998 149 156
158. D. Renault, F. Tombolan, D. Brault, F. Perin, and V. Thybaud Comparative mutagenicity of 7H-dibenzo[c,g]carbazole and two derivatives in Muta™ mouse liver and skin Mutat. Res. 417 1998 129 140
159. S. Takahashi, Y. Kubota, and H. Sato Mutant frequencies in lacZ transgenic mice following the internal irradiation from 89Sr or the external gamma-ray irradiation J. Radiat. Res. (Tokyo) 39 1998 53 60
160. X.B. Zhang, J.S. Felton, J.D. Tucker, C. Urlando, and J.A. Heddle Intestinal mutagenicity of two carcinogenic food mutagens in transgenic mice: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and amino(alpha)carboline Carcinogenesis 17 1996 2259 2265
161. C.D. Davis, E.J. Dacquel, H.A. Schut, S.S. Thorgeirsson, and E.G. Snyderwine In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta mice and c-myc/lacZ double transgenic mice Mutat. Res. 356 1996 287 296
162. J. Ashby, D. Brusick, B.C. Myhr, N.J. Jones, J.M. Parry, S. Nesnow, D. Paton, H. Tinwell, H.S. Rosenkranz, and S. Curti Correlation of carcinogenic potency with mouse-skin 32P-postlabeling and muta-Rmouse lac Z- mutation data for DMBA and its K-region sulphur isostere: comparison with activities observed in standard genotoxicity assays Mutat. Res. 292 1993 25 40
163. N.J. Gorelick, J.L. Andrews, M. Gu, and B.W. Glickman Mutational spectra in the lacl gene in skin from 7,12- dimethylbenz[a]anthracene-treated and untreated transgenic mice Mol. Carcinog. 14 1995 53 62
164. T.J. Monroe, and M.A. Mitchell In vivo mutagenesis induced by CC-1065 and adozelesin DNA alkylation in a transgenic mouse model Cancer Res. 53 1993 5690 5696
165. H. Autrup, E.C. Jorgensen, and O. Jensen Aflatoxin B1 induced lacI mutation in liver and kidney of transgenic mice C57BL/6N: effect of phorone Mutagenesis 11 1996 69 73
166. R. Davies, T.W. Gant, L.L. Smith, and J.A. Styles Tamoxifen induces G:C → T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5′-CpG-3′ dinucleotide sequences as found in the lacI transgene Carcinogenesis 20 1999 1351 1356
167. R. Davies, V.I. Oreffo, E.A. Martin, M.F. Festing, I.N. White, L.L. Smith, and J.A. Styles Tamoxifen causes gene mutations in the livers of lambda/lacI transgenic rats Cancer Res. 57 1997 1288 1293
168. C.C. Smith, G.E. Archer, E.J. Forster, T.R. Lambert, R.W. Rees, and A.M. Lynch Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in Muta™ mouse Environ. Mol. Mutagen. 34 1999 131 139
169. A.H. Mullin, R. Rando, F. Esmundo, and D.A. Mullin Inhalation of benzene leads to an increase in the mutant frequencies of a lacI transgene in lung and spleen tissues of mice Mutat. Res. 327 1995 121 129
170. L. Cosentino, and J.A. Heddle Differential mutation of transgenic and endogenous loci in vivo (In Process Citation) Mutat. Res. 454 2000 1 10
171. L. Cosentino, and J.A. Heddle A comparison of the effects of diverse mutagens at the lacZ transgene and Dlb-1 locus in vivo Mutagenesis 14 1999 113 119
172. A. Hakura, Y. Tsutsui, J. Sonoda, J. Kai, T. Imade, M. Shimada, Y. Sugihara, and T. Mikami Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta™ mouse) Mutat. Res. 398 1998 123 130
173. A. Hakura, Y. Tsutsui, J. Sonoda, T. Mikami, K. Tsukidate, F. Sagami, and W.D. Kerns Multiple organ mutation in the lacZ transgenic mouse (Muta™ mouse) 6 months after oral treatment (5 days) with benzo[a]pyrene Mutat. Res. 426 1999 71 77
174. W. Kosinska, M.D. von Pressentin, and J.B. Guttenplan Mutagenesis induced by benzo[a]pyrene in lacZ mouse mammary and oral tissues: comparisons with mutagenesis in other organs and relationships to previous carcinogenicity assays Carcinogenesis 20 1999 1103 1106
175. J.B. Guttenplan, M. Chen, W. Kosinska, S. Thompson, Z. Zhao, and L.A. Cohen Effects of a lycopene-rich diet on spontaneous and benzo[a]pyrene- induced mutagenesis in prostate, colon and lungs of the lacZ mouse Cancer Lett. 164 2001 1 6
176. A. de Vries, C.T. van Oostrom, P.M. Dortant, R.B. Beems, C.F. van Kreijl, P.J. Capel, H. van, and Steeg Spontaneous liver tumors and benzo[a]pyrene- induced lymphomas in XPA-deficient mice Mol. Carcinog. 19 1997 46 53
177. H. van Steeg The role of nucleotide excision repair and loss of p53 in mutagenesis and carcinogenesis Toxicol. Lett. 120 2001 209 219
178. S.W. Dean, A. Coates, T.M. Brooks, and B. Burlinson Benzo[a]pyrene site of contact mutagenicity in skin of Muta™ mouse Mutagenesis 13 1998 515 518
179. M.L. Miller, K. Vasunia, G. Talaska, A. Andringa, J. deBoer, and K. Dixon The tumor promoter TPA enhances benzo[a]pyrene and benzo[a]pyrene diolepoxide mutagenesis in Big Blue mouse skin Environ. Mol. Mutagen. 35 2000 319 327
180. D. Brault, D. Renault, F. Tombolan, and V. Thybaud Kinetics of induction of DNA damage and lacZ gene mutations in stomach mucosa of mice treated with beta-propiolactone and N-methyl-N′-nitro-N- nitrosoguanidine, using single-cell gel electrophoresis and Muta™ mouse models Environ. Mol. Mutagen. 34 1999 182 189
181. D. Brault, C. Bouilly, D. Renault, and V. Thybaud Tissue-specific induction of mutations by acute oral administration of N-methyl-N′-nitro- N-nitrosoguanidine and beta-propiolactone to the Muta™ mouse: preliminary data on stomach, liver and bone marrow Mutat. Res. 360 1996 83 87
182. J.C. Micillino, C. Coulais, S. Binet, M.C. Bottin, G. Keith, D. Moulin, and B.H. Rihn Lack of genotoxicity of bitumen fumes in transgenic mouse lung Toxicology 170 2002 11 20
183. F. Tombolan, D. Renault, D. Brault, M. Guffroy, F. Perin, and V. Thybaud Effect of mitogenic or regenerative cell proliferation on lacz mutant frequency in the liver of Muta™Mice treated with 5,9- dimethyldibenzo[c,g]carbazole Carcinogenesis 20 1999 1357 1362
184. N. Hachiya, and Y. Motohashi Examination of lacZ mutant induction in the liver and testis of Muta™ mouse following injection of halogenated aliphatic hydrocarbons classified as human carcinogens Ind. Health 38 2000 213 220
185. N. Thein, P. Moller, H. Amtoft, U. Vogel, B. Korsholm, H. Autrup, and H. Wallin A strong genotoxic effect in mouse skin of a single painting of coal tar in hairless mice and in Muta™ mouse Mutat. Res. 468 2000 117 124
186. H. Yang, B.W. Glickman, and J.G. deBoer Effect of conjugated linoleic acid on the formation of spontaneous and PhIP-induced mutation in the colon and cecum of rats Mutat. Res. 2002 157
187. B. Rihn, C. Coulais, E. Kauffer, M.C. Bottin, P. Martin, F. Yvon, J.C. Vigneron, S. Binet, N. Monhoven, G. Steiblen, and G. Keith Inhaled crocidolite mutagenicity in lung DNA Environ. Health Perspect. 108 2000 341 346
188. O. Krebs, B. Schafer, T. Wolff, D. Oesterle, E. Deml, M. Sund, and J. Favor The DNA damaging drug cyproterone acetate causes gene mutations and induces glutathione-S-transferase P in the liver of female Big Blue transgenic F344 rats Carcinogenesis 19 1998 241 245 (published erratum appears in Carcinogenesis 19(4) (1998) 707)
189. T. Wolff, J. Topinka, E. Deml, D. Oesterle, and L.R. Schwarz Dose dependent induction of DNA adducts, gene mutations, and cell proliferation by the antiandrogenic drug cyproterone acetate in rat liver Adv. Exp. Med. Biol. 500 2001 687 696
190. D. Gunz, S.E. Shephard, and W.K. Lutz Can nongenotoxic carcinogens be detected with the lacI transgenic mouse mutation assay? Environ. Mol. Mutagen. 21 1993 209 211 (published erratum appears in Environ. Mol. Mutagen. 22(2) (1993) 123)
191. S.A. Leavitt, A.B. DeAngelo, M.H. George, and J.A. Ross Assessment of the mutagenicity of dichloroacetic acid in lacI transgenic B6C3F1 mouse liver Carcinogenesis 18 1997 2101 2106
192. H. Sato, H. Sone, M. Sagai, K.T. Suzuki, and Y. Aoki Increase in mutation frequency in lung of Big Blue rat by exposure to diesel exhaust Carcinogenesis 21 2000 653 661
193. B.B. Gollapudi, K.M. Jackson, and W.T. Stott Hepatic lacI and cII mutation in transgenic (lambdaLIZ) rats treated with dimethylnitrosamine Mutat. Res. 419 1998 131 135
194. B.E. Butterworth, M.V. Templin, A.A. Constan, C.S. Sprankle, B.A. Wong, L.J. Pluta, J.I. Everitt, and L. Recio Long-term mutagenicity studies with chloroform and dimethylnitrosamine in female lacI transgenic B6C3F1 mice Environ. Mol. Mutagen. 31 1998 248 256
195. H. Tinwell, U. Liegibel, O. Krebs, P. Schmezer, J. Favor, and J. Ashby Comparison of lacI and lacZ transgenic mouse mutation assays: an EU- sponsored interlaboratory study Mutat. Res. 335 1995 185 190
196. S.E. Shephard, D. Gunz, and C. Schlatter Genotoxicity of agaritine in the lacI transgenic mouse mutation assay: evaluation of the health risk of mushroom consumption Food Chem. Toxicol. 33 1995 257 264
197. H. Tinwell, P.A. Lefevre, and J. Ashby Response of the Muta™ mouse lacZ/galE- transgenic mutation assay to DMN: comparisons with the corresponding Big Blue (lacI) responses Mutat. Res. 307 1994 169 173
198. H. Tinwell, P.A. Lefevre, and J. Ashby Relative activities of methyl methanesulphonate (MMS) as a genotoxin, clastogen and gene mutagen to the liver and bone marrow of Muta™ mouse mice Environ. Mol. Mutagen. 32 1998 163 172
199. J. Jiao, G.R. Douglas, J.D. Gingerich, and L.M. Soper Analysis of tissue-specific lacZ mutations induced by N-nitrosodibenzylamine in transgenic mice Carcinogenesis 18 1997 2239 2245
200. P.A. Lefevre, H. Tinwell, S.M. Galloway, R. Hill, J.M. Mackay, C.R. Elcombe, J. Foster, V. Randall, R.D. Callander, and J. Ashby Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta™ mouse and Big Blue transgenic mice Hum. Exp. Toxicol. 13 1994 764 775
201. H. Tinwell, P.A. Lefevre, and J. Ashby Mutation studies with dimethyl nitrosamine in young and old lacI transgenic mice Mutat. Res. 307 1994 501 508
202. S.C. Sisk, L.J. Pluta, K.G. Meyer, B.C. Wong, and L. Recio Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure Mutat. Res. 391 1997 153 164
203. C.J. Rompelberg, M.J. Steenwinkel, J.G. van Asten, J.H. van Delft, R.A. Baan, and H. Verhagen Effect of eugenol on the mutagenicity of benzo[a]pyrene and the formation of benzo[a]pyrene-DNA adducts in the lambda-lacZ-transgenic mouse Mutat. Res. 369 1996 87 96
204. X.B. Zhang, K. Tao, C. Urlando, P. Shaver-Walker, and J.A. Heddle Mutagenicity of high fat diets in the colon and small intestine of transgenic mice Mutagenesis 11 1996 43 48
205. G.R. Douglas, J.D. Gingerich, and L.M. Soper Evidence for in vivo non-mutagenicity ofthe carcinogen hydrazine sulfate in target tissues of lacZ transgenic mice Carcinogenesis 16 1995 801 804
206. S.A. Bol, J. Horlbeck, J. Markovic, J.G. deBoer, R.J. Turesky, and A. Constable Mutational analysis of the liver, colon and kidney of Big Blue rats treated with 2-amino-3-methylimidazo[4,5-f]quinoline Carcinogenesis 21 2000 1 6
207. P. Moller, H. Wallin, U. Vogel, H. Autrup, L. Risom, M.T. Hald, B. Daneshvar, L.O. Dragsted, H.E. Poulsen, and S. Loft Mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in colon and liver of Big Blue rats: role of DNA adducts, strand breaks, DNA repair and oxidative stress Carcinogenesis 23 2002 1379 1385
208. T. Suzuki, T. Itoh, M. Hayashi, Y. Nishikawa, S. Ikezaki, F. Furukawa, M. Takahashi, and T. Sofuni Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice Environ. Mol. Mutagen. 28 1996 348 353
209. D.Y. Ryu, V.S. Pratt, C.D. Davis, H.A. Schut, and E.G. Snyderwine In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice Cancer Res. 59 1999 2587 2592
210. V. Pletsa, M.J. Steenwinkel, J.H. van Delft, R.A. Baan, and S.A. Kyrtopoulos Methyl bromide causes DNA methylation in rats and mice but fails to induce somatic mutations in lambda lacZ transgenic mice Cancer Lett. 135 1999 21 27
211. E. Touati, M. Hofnung, J.M. Thiberge, V. Michel, A. Labigne, and P.J. Jenks Short-term infection with Helicobacter pylori and 1 week exposure to metronidazole does not enhance gastric mutation frequency in transgenic mice J. Antimicrob. Chemother. 46 2000 987 992
212. ® rats and Muta™ mouse mice in vivo after inhalation Mutat. Res. 420 1998 85 98
213. J. Ashby, J.M. Short, N.J. Jones, P.A. Lefevre, G.S. Provost, B.J. Rogers, E.A. Martin, J.M. Parry, K. Burnette, and B.W. Glickman Mutagenicity of o-anisidine to the bladder of lacI- transgenic B6C3F1 mice: absence of 14C or 32P bladder DNA adduction Carcinogenesis 15 1994 2291 2296
214. ® mice and induction of tandem-base substitutions in Salmonella by the air pollutant peroxyacetyl nitrate (PAN): predicted formation of intrastrand cross-links Mutat. Res. 457 2000 41 55
215. J.A. Styles, R. Davies, S. Fenwick, J. Walker, I.N. White, and L.L. Smith Tamoxifen mutagenesis and carcinogenesis in livers of lambda/lacI transgenic rats: selective influence of phenobarbital promotion Cancer Lett. 162 2001 117 122
216. H. Okonogi, G.R. Stuart, E. Okochi, T. Ushijima, T. Sugimura, B.W. Glickman, and M. Nagao Effects of gender and species on spectra of mutation induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the lacI transgene Mutat. Res. 395 1997 93 99
217. -/- mice Carcinogenesis 22 2001 619 626
218. G.R. Stuart, E. Thorleifson, E. Okochi, J.G. deBoer, T. Ushijima, M. Nagao, and B.W. Glickman Interpretation of mutational spectra from different genes: analyses of PhIP-induced mutational specificity in the lacI and cII transgenes from colon of Big Blue rats Mutat. Res. 452 2000 101 121
219. K. Masumura, K. Matsui, M. Yamada, M. Horiguchi, K. Ishida, M. Watanabe, O. Ueda, H. Suzuki, Y. Kanke, K.R. Tindall, K. Wakabayashi, T. Sofuni, and T. Nohmi Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the new gpt delta transgenic mouse Cancer Lett. 143 1999 241 244
220. A.M. Lynch, N.J. Gooderham, and A.R. Boobis Organ distinctive mutagenicity in Muta™ mouse after short-term exposure to PhIP Mutagenesis 11 1996 505 509
221. G.R. Stuart, J.G. deBoer, R. Haesevoets, J. Holcroft, J. Kangas, K. Sojonky, E. Thorleifson, A. Thornton, D.F. Walsh, H. Yang, and B.W. Glickman Mutations induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in cecum and proximal and distal colon of lacI transgenic rats Mutagenesis 16 2001 431 437
222. H. Yang, G.R. Stuart, B.W. Glickman, and J. deBoer Modulation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutation in the cecum and colon of big blue rats by conjugated linoleic acid and 1,2-dithiole-3-thione Nut. Cancer 39 2001 259 266
223. L.O. Dragsted, B. Daneshvar, U. Vogel, H.N. Autrup, H. Wallin, L. Risom, P. Moller, A.M. Molck, M. Hansen, H.E. Poulsen, and S. Loft A sucrose-rich diet induces mutations in the rat colon Cancer Res. 62 2002 4339 4345
224. G.R. Douglas, J.D. Gingerich, L.M. Soper, M. Potvin, and S. Bjarnason Evidence for the lack of base-change and small-deletion mutation induction by trichloroethylene in lacZ transgenic mice Environ. Mol. Mutagen. 34 1999 190 194
225. J.G. deBoer, J.C. Mirsalis, G.S. Provost, K.R. Tindall, and B.W. Glickman Spectrum of mutations in kidney, stomach, and liver from lacI transgenic mice recovered after treatment with tris(2,3- dibromopropyl)phosphate Environ. Mol. Mutagen. 28 1996 418 423
226. G.S. Provost, J.C. Mirsalis, B.J. Rogers, and J.M. Short Mutagenic response to benzene and tris(2,3-dibromopropyl)-phosphate in the lambda lacI transgenic mouse mutation assay: a standardized approach to in vivo mutation analysis Environ. Mol. Mutagen. 28 1996 342 347
227. P.Y. Chang, J. Mirsalis, E.S. Riccio, J.P. Bakke, P.S. Lee, J. Shimon, S. Phillips, D. Fairchild, Y. Hara, and J.A. Crowell Genotoxicity and toxicity of the potential cancer-preventive agent polyphenon E Environ. Mol. Mutagen. 41 2003 43 54
228. S.R. Moore, K.A. Hill, P.W. Heinmoller, A. Halangoda, M. Kunishige, V.L. Buettner, K.S. Graham, and S.S. Sommer Spontaneous mutation frequency and pattern in Big Blue mice fed a vitamin E-supplemented diet Environ. Mol. Mutagen. 34 1999 195 200
229. G.R. Douglas, J. Jiao, J.D. Gingerich, J.A. Gossen, and L.M. Soper Temporal and molecular characteristics of mutations induced by ethylnitrosourea in germ cells isolated from seminiferous tubules and in spermatozoa of lacZ transgenic mice Proc. Natl. Acad. Sci. U.S.A. 92 1995 7485 7489
230. H. Ikehata, M. Takatsu, Y. Saito, and T. Ono Distribution of spontaneous CpG-associated G:C → A:T mutations in the lacZ gene of Muta mice: effects of CpG methylation, the sequence context of CpG sites, and severity of mutations on the activity of the lacZ gene product Environ. Mol. Mutagen. 36 2000 301 311
231. J.J. Monroe, M.G. Manjanatha, and T.R. Skopek Extent of CpG methylation is not proportional to the in vivo spontaneous mutation frequency at transgenic loci in Big Blue rodents Mutat. Res. 476 2001 1 11
232. Y.H. You, A. Halangoda, V. Buettner, K. Hill, S. Sommer, and G. Pfeifer Methylation of CpG dinucleotides in the lacI gene of the Big Blue transgenic mouse Mutat. Res. 420 1998 55 65
233. T. Chen, A. Aidoo, M.G. Manjanatha, R.A. Mittelstaedt, S.D. Shelton, L.E. Lyn-Cook, D.A. Casciano, and R.H. Heflich Comparison of mutant frequencies and types of mutations induced by thiotepa in the endogenous Hprt gene and transgenic lacI gene of Big Blue rats Mutat. Res. 403 1998 199 214
234. P.C. Hanawalt, J.M. Ford, and D.R. Lloyd Functional characterization of global genomic DNA repair and its implications for cancer Mutat. Res. 544 2003 107 114
235. J.A. Heddle, L. Cosentino, G. Dawod, R.R. Swiger, and Y. Paashuis-Lew Why do stem cells exist? Environ. Mol. Mutagen. 28 1996 334 341
236. Bioassay of Tris(2,3-dibromopropyl) Phosphate for Possible Carcinogenicity (CAS No. 126-72-7), NTP, DHEW (NIH) Publication No. 78-1326, Bethesda, MD, National Institutes of Health, Carcinogenesis, Technical Report Series No. 76, 1978.
237. S. Yamamoto, T. Kasai, M. Matsumoto, T. Nishizawa, H. Arito, K. Nagano, and T. Matsushima Carcinogenicity and chronic toxicity in rats and mice exposed to chloroform by inhalation J. Occup. Health 44 2002 283 293
238. W. Lijinsky, R.M. Kovatch, and B.J. Thomas The carcinogenic effect of methapyrilene combined with nitrosodiethylamine given to rats in low doses Carcinogenesis 13 1992 1293 1297
239. D.W. Lynch, T.R. Lewis, W.J. Moorman, J.R. Burg, D.H. Groth, A. Khan, L.J. Ackerman, and B.Y. Cockrell Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 rats Toxicol. Appl. Pharmacol. 76 1984 69 84
240. H. Esumi, H. Ohgaki, E. Kohzen, S. Takayama, and T. Sugimura Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine Jpn. J. Cancer Res. 80 1989 1176 1178
241. V.N. Anisimov Carcinogenesis and aging. I. Modifying effects of aging on N-methyl-N-nitrosourea-induced carcinogenesis in female rats Exp. Pathol. 19 1981 81 90
242. NTP, Toxicology and Carcinogenesis Studies of d-Limonene (CAS No. 5989-27-5) in F344/N rats and B6C3F1 mice (Gavage Studies), Natl. Toxicol. Program Tech. Rep. Ser. 347 (1990) 1-165.
243. C.R. Elcombe, J. Odum, J.R. Foster, S. Stone, S. Hasmall, A.R. Soames, I. Kimber, and J. Ashby Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens Environ. Health Perspect. 110 2002 363 375
244. J. Whysner, and G.M. Williams d-Limonene mechanistic data and risk assessment: absolute species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion Pharmacol. Ther. 71 1996 127 136
245. L.H. Danse, F.L. van Velsen, and C.A. van der Heijden Methylbromide: carcinogenic effects in the rat forestomach Toxicol. Appl. Pharmacol. 72 1984 262 271
246. M. Tatematsu, M. Yamamoto, H. Iwata, H. Fukami, H. Yuasa, N. Tezuka, T. Masui, and H. Nakanishi Induction of glandular stomach cancers in C3H mice treated with N-methyl-N-nitrosourea in the drinking water Jpn. J. Cancer Res. 84 1993 1258 1264
247. W. Lijinsky, and R.M. Kovatch Similar carcinogenic actions of nitrosoalkylureas of varying structure given to rats by gavage Toxicol. Ind. Health 5 1989 925 935
248. L.B. Ellwein, and S.M. Cohen The health risks of saccharin revisited Crit. Rev. Toxicol. 20 1990 311 326
249. J.M. Ward, J.M. Sontag, E.K. Weisburger, and C.A. Brown Effect of lifetime exposure to aflatoxin b1 in rats J. Natl. Cancer Inst. 55 1975 107 113
250. T.R. Skopek, K.L. Kort, D.R. Marino, L.V. Mittal, D.R. Umbenhauer, G.M. Laws, and S.P. Adams Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice Environ. Mol. Mutagen. 28 1996 376 384
251. J.J. Monroe, K.L. Kort, J.E. Miller, D.R. Marino, and T.R. Skopek A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice Mutat. Res. 421 1998 121 136
252. A. Kohara, T. Suzuki, M. Honma, T. Oomori, T. Ohwada, and M. Hayashi Dinitropyrenes induce gene mutations in multiple organs of the lambda/lacZ transgenic mouse (Muta™ mouse) Mutat. Res. 515 2002 73 83
253. ® transgenic mice Mutat. Res. 452 2000 197 210
254. D.M. Zimmer, P.R. Harbach, W.B. Mattes, and C.S. Aaron Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice Environ. Mol. Mutagen. 33 1999 249 256
255. A. Kohara, T. Suzuki, M. Honma, T. Ohwada, and M. Hayashi Mutagenicity of aristolochic acid in the lambda/lacZ transgenic mouse (Muta™ mouse) Mutat. Res. 515 2002 63 72
256. N. Hachiya, N. Yajima, S. Hatakeyama, K. Yuno, N. Okada, Y. Umeda, A. Wakata, and Y. Motohashi Induction of lacZ mutation by 7,12-dimethylbenz[a] anthracene in various tissues of transgenic mice Mutat. Res. 444 1999 283 295
257. A. Kohara, T. Suzuki, M. Honma, N. Hirano, K. Ohsawa, T. Ohwada, and M. Hayashi Mutation spectrum of o-aminoazotoluene in the cII gene of lambda/lacZ transgenic mice (Muta™ mouse) Mutat. Res. 491 2001 211 220
258. N. Shima, R.R. Swiger, and J.A. Heddle Dietary restriction during murine development provides protection against MNU-induced mutations Mutat. Res. 470 2000 189 200
259. K. Ohsawa, N. Hirano, M. Sugiura, S. Nakagawa, and M. Kimura Genotoxicity of o-aminoazotoluene (AAT) determined by the Ames test, the in vitro chromosomal aberration test, and the transgenic mouse gene mutation assay Mutat. Res. 471 2000 113 126
260. Y. Miyata, K. Saeki, Y. Kawazoe, M. Hayashi, T. Sofuni, and T. Suzuki Antimutagenic structural modification of quinoline assessed by an in vivo mutagenesis assay using lacZ-transgenic mice Mutat. Res. 414 1998 165 169
261. P.R. Harbach, D.M. Zimmer, A.L. Filipunas, W.B. Mattes, and C.S. Aaron Spontaneous mutation spectrum at the lambda cII locus in liver, lung, and spleen tissue of Big Blue transgenic mice Environ. Mol. Mutagen. 33 1999 132 143
262. T. Suzuki, X. Wang, Y. Miyata, K. Saeki, A. Kohara, Y. Kawazoe, M. Hayashi, and T. Sofuni Hepatocarcinogen quinoline induces G:C to C:G transversions in the cII gene in the liver of lambda/lacZ transgenic mice (Muta™ mouse) Mutat. Res. 456 2000 73 81
263. B.C. Myhr Validation studies with Muta™ mouse: a transgenic mouse model for detecting mutations in vivo Environ. Mol. Mutagen. 18 1991 308 315
264. A.J. Hoorn, L.L. Custer, B.C. Myhr, D. Brusick, J. Gossen, and J. Vijg Detection of chemical mutagens using Muta™ mouse: a transgenic mouse model Mutagenesis 8 1993 7 10
265. T. Suzuki, M. Hayashi, M. Ochiai, K. Wakabayashi, T. Ushijima, T. Sugimura, M. Nagao, and T. Sofuni Organ variation in the mutagenicity of MeIQ in Big Blue lacI transgenic mice Mutat. Res. 369 1996 45 49
266. V.L. Souliotis, J.H. van Delft, M.J. Steenwinkel, R.A. Baan, and S.A. Kyrtopoulos DNA adducts, mutant frequencies and mutation spectra in lambda lacZ transgenic mice treated with N-nitrosodimethylamine Carcinogenesis 19 1998 731 739
267. J.G. deBoer, S. Provost, N. Gorelick, K. Tindall, and B.W. Glickman Spontaneous mutation in lacI transgenic mice: a comparison of tissues Mutagenesis 13 1998 109 114
268. K.A. Hill, V.L. Buettner, B.W. Glickman, and S.S. Sommer Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived Mutat. Res. 436 1999 11 19
269. V.L. Buettner, H. Nishino, J. Haavik, A. Knoll, K. Hill, and S.S. Sommer Spontaneous mutation frequencies and spectra in p53(+/+) and p53(-/-) mice: a test of the 'guardian of the genome' hypothesis in the Big Blue transgenic mouse mutation detection system Mutat. Res. 379 1997 13 20
270. H. Nishino, V.L. Buettner, J. Haavik, D.J. Schaid, and S.S. Sommer Spontaneous mutation in Big Blue transgenic mice: analysis of age, gender, and tissue type Environ. Mol. Mutagen. 28 1996 299 312
271. T. Ono, H. Ikehata, S. Nakamura, Y. Saito, Y. Hosoi, Y. Takai, S. Yamada, J. Onodera, and K. Yamamoto Age-associated increase of spontaneous mutant frequency and molecular nature of mutation in newborn and old lacZ-transgenic mouse Mutat. Res. 447 2000 165 177
272. M.E. Dolle, W.K. Snyder, J.A. Gossen, P.H. Lohman, and J. Vijg Distinct spectra of somatic mutations accumulated with age in mouse heart and small intestine Proc. Natl. Acad. Sci. U.S.A. 97 2000 8403 8408
273. T. Ono, Y. Miyamura, H. Ikehata, H. Yamanaka, A. Kurishita, K. Yamamoto, T. Suzuki, T. Nohmi, M. Hayashi, and T. Sofuni Spontaneous mutant frequency of lacZ gene in spleen of transgenic mouse increases with age Mutat. Res. 338 1995 183 188
274. M.E. Dolle, H. Giese, C.L. Hopkins, H.J. Martus, J.M. Hausdorff, and J. Vijg Rapid accumulation of genome rearrangements in liver but not in brain of old mice (see comments) Nat. Genet. 17 1997 431 434
275. G.R. Stuart, Y. Oda, J.G. deBoer, and B.W. Glickman Mutation frequency and specificity with age in liver, bladder and brain of lacI transgenic mice Genetics 154 2000 1291 1300
276. A.T. Lee, C. DeSimone, A. Cerami, and R. Bucala Comparative analysis of DNA mutations in lacI transgenic mice with age FASEB J. 8 1994 545 550
277. V.L. Buettner, K.A. Hill, A. Halangoda, and S.S. Sommer Tandem-base mutations occur in mouse liver and adipose tissue preferentially as G:C to T:A transversions and accumulate with age Environ. Mol. Mutagen. 33 1999 320 324
278. ® rats treated with 7, 12- dimethylbenz[a]anthracene (in process citation) Environ. Mol. Mutagen. 36 2000 235 242
279. S. Takahashi, Y. Ikeda, N. Kimoto, E. Okochi, L. Cui, M. Nagao, T. Ushijima, and T. Shirai Mutation induction by mechanical irritation caused by uracil-induced urolithiasis in Big Blue rats Mutat. Res. 447 2000 275 280
280. S. Zhang, B.W. Glickman, and J.G. deBoer Spontaneous mutation of the lacI transgene in rodents: absence of species, strain, and insertion-site influence Environ. Mol. Mutagen. 37 2001 141 146
281. J.F. O'Sullivan, G.H. Schmidt, and D. Paul Spontaneous mutation rate Nature 352 1991 200 201
282. S.L. Martin, C.L. Hopkins, A. Naumer, M.E. Dolle, and J. Vijg Mutation frequency and type during ageing in mouse seminiferous tubules Mech. Ageing Dev. 122 2001 1321 1331
283. C.A. Walter, G.W. Intano, J.R. McCarrey, C.A. McMahan, and R.B. Walter Mutation frequency declines during spermatogenesis in young mice but increases in old mice Proc. Natl. Acad. Sci. U.S.A. 95 1998 10015 10019
284. C.A. Walter, G.W. Intano, C.A. McMahan, K. Kelner, J.R. McCarrey, and R.B. Walter Mutation spectral changes in spermatogenic cells obtained from old mice DNA Repair (Amst.) 3 2004 495 504
285. K.S. Tao, C. Urlando, and J.A. Heddle Mutagenicity of methyl methanesulfonate (MMS) in vivo at the Dlb-1 native locus and a lacI transgene Environ. Mol. Mutagen. 22 1993 293 296
286. L. Cosentino, and J.A. Heddle Effects of extended chronic exposures on endogenous and transgenic loci: implications for low-dose extrapolations Environ. Mol. Mutagen. 34 1999 208 215
287. K.P. Hoyes, P.J. Wadeson, H.L. Sharma, J.H. Hendry, and I.D. Morris Mutation studies in lacI transgenic mice after exposure to radiation or cyclophosphamide Mutagenesis 13 1998 607 612
288. J.H. van Delft, and R.A. Baan Germ cell mutagenesis in lambda lacZ transgenic mice treated with ethylnitrosourea; comparison with specific-locus test Mutagenesis 10 1995 209 214
289. K.S. Tao, and J.A. Heddle The accumulation and persistence of somatic mutations in vivo Mutagenesis 9 1994 187 191
290. P.M. Shaver-Walker, C. Urlando, K.S. Tao, X.B. Zhang, and J.A. Heddle Enhanced somatic mutation rates induced in stem cells of mice by low chronic exposure to ethylnitrosourea Proc. Natl. Acad. Sci. U.S.A. 92 1995 11470 11474
291. ® rats treated with the hepatocarcinogen N-hydroxy-2-acetylaminofluorene Environ. Mol. Mutagen. 37 2001 203 214
292. G.R. Douglas, J. Jiao, J.D. Gingerich, L.M. Soper, and J.A. Gossen Temporal and molecular characteristics of lacZ mutations in somatic tissues of transgenic mice Environ. Mol. Mutagen. 28 1996 317 324
293. ® mice (in process citation) Environ. Mol. Mutagen. 36 2000 266 273
294. M. Nakajima, M. Kikuchi, K. Saeki, Y. Miyata, M. Terada, F. Kishida, R. Yamamoto, C. Furihata, and S.W. Dean Mutagenicity of 4-nitroquinoline 1-oxide in the Muta™ mouse Mutat. Res. 444 1999 321 336
295. F. Tombolan, D. Renault, D. Brault, M. Guffroy, O. Perin-Roussel, F. Perin, and V. Thybaud Kinetics of induction of DNA adducts, cell proliferation and gene mutations in the liver of MutaMice treated with 5,9- dimethyldibenzo[c,g]carbazole Carcinogenesis 20 1999 125 132
296. E.J. Mientjes, M.J. Steenwinkel, J.H. van Delft, P.H. Lohman, and R.A. Baan Comparison of the X-gal- and P-gal-based systems for screening of mutant lambda lacZ phages originating from the transgenic mouse strain 40.6 Mutat. Res. 360 1996 101 106
297. N. Okada, A. Honda, M. Kawabata, and N. Yajima Sodium phenobarbital-enhanced mutation frequency in the liver DNA of lacZ transgenic mice treated with diethylnitrosamine Mutagenesis 12 1997 179 184
298. E.J. Mientjes, A. Luiten-Schuite, W.E. van der, Y. Borsboom, A. Bergmans, F. Berends, P.H. Lohman, R.A. Baan, and J.H. van Delft DNA adducts, mutant frequencies, and mutation spectra in various organs of lambda lacZ mice exposed to ethylating agents Environ. Mol. Mutagen. 31 1998 18 31
299. O. Krebs, and J. Favor Somatic and germ cell mutagenesis in lambda lacZ transgenic mice treated with acrylamide or ethylnitrosourea Mutat. Res. 388 1997 239 248
300. J.C. Mirsalis, G.S. Provost, C.D. Matthews, R.T. Hamner, J.E. Schindler, K.G. O'Loughlin, J.T. MacGregor, and J.M. Short Induction of hepatic mutations in lacI transgenic mice Mutagenesis 8 1993 265 271
301. N. Okada, K. Masumura, T. Nohmi, and N. Yajima Efficient detection of deletions induced by a single treatment of mitomycin C in transgenic mouse gpt delta using the spi(-) selection Environ. Mol. Mutagen. 34 1999 106 111
302. T. Hara, K. Hirano, N. Hirano, H. Tamura, H. Sui, T. Shibuya, A. Hyogo, T. Hirashio, H. Tokai, Y. Yamashita, and K. Kura Mutation induction by N-propyl-N-nitrosourea in eight Muta™ mouse organs Mutat. Res. 444 1999 297 307
303. J. Ashby Transgenic germ cell mutation assays: a small collaborative study Environ. Mol. Mutagen. 25 1995 1 3
304. W.W. Piegorsch, A.M. Lockhart, B.H. Margolin, K.R. Tindall, N.J. Gorelick, J.M. Short, G.J. Carr, E.D. Thompson, and M.D. Shelby Sources of variability in data from a lacI transgenic mouse mutation assay Environ. Mol. Mutagen. 23 1994 17 31
305. W.W. Piegorsch, A.C. Lockhart, G.J. Carr, B.H. Margolin, T. Brooks, G.R. Douglas, U.M. Liegibel, T. Suzuki, V. Thybaud, J.H. van Delft, and N.J. Gorelick Sources of variability in data from a positive selection lacZ transgenic mouse mutation assay: an interlaboratory study Mutat. Res. 388 1997 249 289
306. G.J. Carr, and N.J. Gorelick Statistical tests of significance in transgenic mutation assays: considerations on the experimental unit Environ. Mol. Mutagen. 24 1994 276 282
307. G.J. Carr, and N.J. Gorelick Statistical design and analysis of mutation studies in transgenic mice Environ. Mol. Mutagen. 25 1995 246 255
308. W.W. Piegorsch, B.H. Margolin, M.D. Shelby, A. Johnson, J.E. French, R.W. Tennant, and K.R. Tindall Study design and sample sizes for a lacI transgenic mouse mutation assay Environ. Mol. Mutagen. 25 1995 231 245
309. T. Suzuki, M. Hayashi, and T. Sofuni Initial experiences and future directions for transgenic mouse mutation assays Mutat. Res. 307 1994 489 494
310. T. Suzuki, M. Hayashi, X. Wang, K. Yamamoto, T. Ono, B.C. Myhr, and T. Sofuni A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta™ mouse) Mutat. Res. 395 1997 75 82
311. T. Suzuki, M. Hayashi, T. Sofuni, and B.C. Myhr The concomitant detection of gene mutation and micronucleus induction by mitomycin C in vivo using lacZ transgenic mice Mutat. Res. 285 1993 219 224
312. S. Itoh, M. Miura, and H. Shimada Lack of mutagenicity of levofloxacin in lacZ transgenic mice Mutagenesis 13 1998 51 55
313. T.M. Brooks, and S.W. Dean Detection of gene mutation in skin, stomach and liver of Muta™ mouse following oral or topical treatment with N-methyl-N′-nitro-N-nitrosoguanidine or 1-chloromethylpyrene: some preliminary observations Mutagenesis 11 1996 529 532
314. T. Suzuki, Y. Miyata, K. Saeki, Y. Kawazoe, M. Hayashi, and T. Sofuni In vivo mutagenesis by the hepatocarcinogen quinoline in the lacZ transgenic mouse: evidence for its in vivo genotoxicity Mutat. Res. 412 1998 161 166
315. K.Y. Fung, G.R. Douglas, and D. Krewski Statistical analysis of lacZ mutant frequency data from Muta™ mouse mutagenicity assays Mutagenesis 13 1998 249 255
316. V. Pletsa, C. Valavanis, J.H. van Delft, M.J. Steenwinkel, and S.A. Kyrtopoulos DNA damage and mutagenesis induced by procarbazine in lambda lacZ transgenic mice: evidence that bone marrow mutations do not arise primarily through miscoding by O6-methylguanine Carcinogenesis 18 1997 2191 2196
317. M.L. Cunningham, J.J. Hayward, B.S. Shane, and K.R. Tindall Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the Big Blue transgenic mouse (see comments) Environ. Health Perspect. 104 Suppl 3 1996 683 686
318. J.J. Hayward, B.S. Shane, K.R. Tindall, and M.L. Cunningham Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene Carcinogenesis 16 1995 2429 2433
319. Y. Paashuis-Lew, X.B. Zhang, and J.A. Heddle On the origin of spontaneous somatic mutations and sectored plaques detected in transgenic mice Mutat. Res. 373 1997 277 284
320. H. Nishino, V.L. Buettner, and S.S. Sommer Towards validation of the Big Blue transgenic mouse mutagenesis assay: the mutational spectrum of ex vivo pinpoint mutant plaques Mutat. Res. 372 1996 97 105
321. H. Sui, M. Suzuki, M. Yamada, T. Hara, K. Kawakami, T. Shibuya, T. Nohmi, and T. Sofuni Effects of O(6)-alkylguanine-DNA alkyltransferase deficiency in Escherichia coli as the host for the detection of mutations in lacI transgenic mice Environ. Mol. Mutagen. 34 1999 221 226
322. P.B. Moens, J.A. Heddle, B. Spyropoulos, and H.H. Heng Identical megabase transgenes on mouse chromosomes 3 and 4 do not promote ectopic pairing or synapsis at meiosis Genome 40 1997 770 773
323. J.A. Heddle, K. Tao, R.R. Swiger, and J.D. Tucker The transmission rate of the lacI transgene from the Big Blue mouse Mutat. Res. 348 1995 63 66
324. V.E. Walker, J.L. Andrews, P.B. Upton, T.R. Skopek, J.G. deBoer, D.M. Walker, X. Shi, H.E. Sussman, and N.J. Gorelick Detection of cyclophosphamide-induced mutations at the Hprt but not the lacI locus in splenic lymphocytes of exposed mice Environ. Mol. Mutagen. 34 1999 167 181
325. ® rats treated with 7, 12- dimethylbenz[a]anthracene Mutat. Res. 401 1998 165 178
326. ® rats Environ. Mol. Mutagen. 37 2001 195 202
327. T.R. Skopek, K.L. Kort, and D.R. Marino Relative sensitivity of the endogenous hprt gene and lacI transgene in ENU-treated Big Blue B6C3F1 mice Environ. Mol. Mutagen. 26 1995 9 15
328. J.G. deBoer, H. Erfle, D. Walsh, J. Holcroft, J.S. Provost, B. Rogers, K.R. Tindall, and B.W. Glickman Spectrum of spontaneous mutations in liver tissue of lacI transgenic mice Environ. Mol. Mutagen. 30 1997 273 286
329. B.S. Shane, J. deBoer, D.E. Watson, J.K. Haseman, B.W. Glickman, and K.R. Tindall LacI mutation spectra following benzo[a]pyrene treatment of Big Blue mice Carcinogenesis 21 2000 715 725
330. M.J. Dycaico, G.R. Stuart, G.M. Tobal, J.G. deBoer, B.W. Glickman, and G.S. Provost Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1 Carcinogenesis 17 1996 2347 2356
331. L. Recio, L.J. Pluta, and K.G. Meyer The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene Mutat. Res. 401 1998 99 110
332. S.C. Sisk, L.J. Pluta, J.A. Bond, and L. Recio Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene Carcinogenesis 15 1994 471 477
333. L. Recio, K.G. Meyer, L.J. Pluta, O.R. Moss, and C.J. Saranko Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure Environ. Mol. Mutagen. 28 1996 424 429
334. L. Recio, A. Steen, L.J. Pluta, K.G. Meyer, and C.J. Saranko Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms Chem. Biol. Interact. 135-136 2001 325 341
335. A. Hakura, Y. Tsutsui, J. Sonoda, K. Tsukidate, T. Mikami, and F. Sagami Comparison of the mutational spectra of the lacZ transgene in four organs of the Muta™ mouse treated with benzo[a]pyrene: target organ specificity Mutat. Res. 447 2000 239 247
336. H. Louro, M.J. Silva, and M.G. Boavida Mutagenic activity of cisplatin in the lacZ plasmid-based transgenic mouse model Environ. Mol. Mutagen. 40 2002 283 291
337. U. Vogel, N. Thein, P. Moller, and H. Wallin Pharmacological coal tar induces G:C to T:A transversion mutations in the skin of Muta™ mouse Pharmacol. Toxicol. 89 2001 30 34
338. N.J. Gorelick, J.L. Andrews, J.G. deBoer, R. Young, D.P. Gibson, and V.E. Walker Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice Environ. Mol. Mutagen. 34 1999 154 166
339. J.G. deBoer, J.C. Mirsalis, and B.W. Glickman Mutational spectrum of dimethylnitrosamine in the liver of 3- and 6-week-old lacI transgenic mice Environ. Mol. Mutagen. 34 1999 80 83
340. V.E. Walker, N.J. Gorelick, J.L. Andrews, T.R. Craft, J.G. deBoer, B.W. Glickman, and T.R. Skopek Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice Cancer Res. 56 1996 4654 4661
341. K. Masumura, K. Kuniya, T. Kurobe, M. Fukuoka, F. Yatagai, and T. Nohmi Heavy-ion-induced mutations in the gpt delta transgenic mouse: comparison of mutation spectra induced by heavy-ion, X-ray, and gamma-ray radiation Environ. Mol. Mutagen. 40 2002 207 215
342. P.Y. Chang, N. Kanazawa, L. Lutze-Mann, and R.A. Winegar p53 deficiency alters the yield and spectrum of radiation-induced lacZ mutants in the brain of transgenic mice Mutagenesis 16 2001 7 15
343. P.Y. Chang, N. Kanazawa, L. Lutze-Mann, and R. Winegar HZE particle radiation induces tissue-specific and p53-dependent mutagenesis in transgenic animals Phys. Med. 17 Suppl. 1 2001 189 191
344. L. Cheng, D.M. Sonntag, J. deBoer, and K. Dixon Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice J. Environ. Pathol. Toxicol. Oncol. 19 2000 239 249
345. T. Chen, d.C. Gamboa, M.M. Marques, S.D. Shelton, F.A. Beland, and M.G. Manjanatha Mutations induced by alpha-hydroxytamoxifen in the lacI and cII genes of Big Blue transgenic rats Carcinogenesis 23 2002 1751 1757
346. T. Ushijima, Y. Hosoya, M. Ochiai, H. Kushida, K. Wakabayashi, T. Suzuki, M. Hayashi, T. Sofuni, T. Sugimura, and M. Nagao Tissue-specific mutational spectra of 2-amino-3,4-dimethylimidazo[4,5- f]quinoline in the liver and bone marrow of lacI transgenic mice Carcinogenesis 15 1994 2805 2809
347. A. Takeiri, M. Mishima, K. Tanaka, A. Shioda, O. Ueda, H. Suzuki, M. Inoue, K. Masumura, and T. Nohmi Molecular characterization of mitomycin C-induced large deletions and tandem-base substitutions in the bone marrow of gpt delta transgenic mice Chem. Res. Toxicol. 16 2003 171 179
348. O.O. Motorna, H. Martin, G.J. Gentile, and J.M. Gentile Analysis of lacI mutations in Big Blue transgenic mice subjected to parasite-induced inflammation Mutat. Res. 484 2001 69 76
349. A.M. Lynch, N.J. Gooderham, D.S. Davies, and A.R. Boobis Genetic analysis of PHIP intestinal mutations in Muta™ mouse Mutagenesis 13 1998 601 605
350. K. Masumura, K. Matsui, M. Yamada, M. Horiguchi, K. Ishida, M. Watanabe, K. Wakabayashi, and T. Nohmi Characterization of mutations induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the colon of gpt delta transgenic mouse: novel G:Cdeletions beside runs of identical bases Carcinogenesis 21 2000 2049 2056
351. E. Okochi, N. Watanabe, Y. Shimada, S. Takahashi, K. Wakazono, T. Shirai, T. Sugimura, M. Nagao, and T. Ushijima Preferential induction of guanine deletion at 5′-GGGA-3′ in rat mammary glands by 2-amino- 1-methyl-6-phenylimidazo[4,5-b]pyridine Carcinogenesis 20 1999 1933 1938
352. ® rats Mutagenesis 18 2003 195 200
353. M. Yu, M.L. Jones, M. Gong, R. Sinha, H.A. Schut, and E.G. Snyderwine Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the mammary gland of Big Blue rats on high-and low-fat diets Carcinogenesis 23 2002 877 884
354. ® mice Mutagenesis 17 2002 353 359
355. R. Davies, V.I. Oreffo, S. Bayliss, P.A. Dinh, K.S. Lilley, I.N. White, L.L. Smith, and J.A. Styles Mutational spectra of tamoxifen-induced mutations in the livers of lacI transgenic rats Environ. Mol. Mutagen. 28 1996 430 433
356. A.F. Frijhoff, H. Rebel, E.J. Mientjes, M.C. Kelders, M.J. Steenwinkel, R.A. Baan, A.A. van Zeeland, and L. Roza UVB-induced mutagenesis in hairless lambda lacZ-transgenic mice Environ. Mol. Mutagen. 29 1997 136 142
357. M. Horiguchi, K. Masumura, H. Ikehata, T. Ono, Y. Kanke, and T. Nohmi Molecular nature of ultraviolet b light-induced deletions in the murine epidermis Cancer Res. 61 2001 3913 3918
358. M. Horiguchi, K. Masumura, H. Ikehata, T. Ono, Y. Kanke, T. Sofuni, and T. Nohmi UVB-induced gpt mutations in the skin of gpt delta transgenic mice Environ. Mol. Mutagen. 34 1999 72 79
359. T. Ono, H. Ikehata, S. Nakamura, Y. Saito, J. Komura, Y. Hosoi, and K. Yamamoto Molecular nature of mutations induced by a high dose of x-rays in spleen, liver, and brain of the lacZ-transgenic mouse Environ. Mol. Mutagen. 34 1999 97 105
360. W.T. Adams, and T.R. Skopek Statistical test for the comparison of samples from mutational spectra J. Mol. Biol. 194 1987 391 396
361. G.J. Carr, and N.J. Gorelick Mutational spectra in transgenic animal research: data analysis and study design based upon the mutant or mutation frequency Environ. Mol. Mutagen. 28 1996 405 413
362. D.B. Dunson, and K.R. Tindall Bayesian analysis of mutational spectra Genetics 156 2000 1411 1418
363. J. Cohen A coefficient of agreement for nominal scales Edu. Psychol. Measure. 20 1960 37 46
364. B.S. Kim, and B.H. Margolin Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests Environ. Mol. Mutagen. 34 1999 297 304
365. E. Zeiger Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance Regular Toxicol. Pharmacol. 28 1998 85 95
366. E. Zeiger, J.K. Haseman, M.D. Shelby, B.H. Margolin, and R.W. Tennant Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals Environ. Mol. Mutagen. 16 Suppl. 18 1990 1 14
367. R.W. Tennant, B.H. Margolin, M.D. Shelby, E. Zeiger, J.K. Haseman, J. Spalding, W. Caspary, M. Resnick, S. Stasiewicz, and B. Anderson Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays Science 236 1987 933 941
368. G. Klopman, and H.S. Rosenkranz Quantification of the predictivity of some short-term assays for carcinogenicity in rodents Mutat. Res. 253 1991 237 240
369. J. Ashby, M.D. Waters, J. Preston, I.D. Adler, G.R. Douglas, R. Fielder, M.D. Shelby, D. Anderson, T. Sofuni, H.N. Gopalan, G. Becking, and C. Sonich-Mullin IPCS harmonization of methods for the prediction and quantification of human carcinogenic/mutagenic hazard, and for indicating the probable mechanism of action of carcinogens Mutat. Res. 352 1996 153 157
370. F.K. Ennever, and H.S. Rosenkranz The influence of the proportion of carcinogens on the cost-effectiveness of short-term tests Mutat. Res. 197 1988 1 13
371. V.A. Fung, J.C. Barrett, and J. Huff The carcinogenesis bioassay in perspective: application in identifying human cancer hazards Environ. Health Perspect. 103 1995 680 683
372. J. McCann, E. Choi, E. Yamasaki, and B.N. Ames Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals Proc. Natl. Acad. Sci. U.S.A. 72 1975 5135 5139
373. I.F. Purchase, E. Longstaff, J. Ashby, J.A. Styles, D. Anderson, P.A. Lefevre, and F.R. Westwood An evaluation of 6 short-term tests for detecting organic chemical carcinogens Br. J. Cancer 37 1978 873 903
374. R.J. Kociba, D.G. Keyes, J.E. Beyer, R.M. Carreon, C.E. Wade, D.A. Dittenber, R.P. Kalnins, L.E. Frauson, C.N. Park, S.D. Barnard, R.A. Hummel, and C.G. Humiston Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats Toxicol. Appl. Pharmacol. 46 1978 279 303
375. National Toxicology Program, Carcinogenesis Bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin (CAS No. 1746-01-6) in Osborne-Mendel Rats and B6C3F1 Mice (Gavage Study), Natl. Toxicol. Program Tech. Rep. Ser. 209 (1982) 1-195.
376. J. Whysner, and G.M. Williams 2,3,7,8-Tetrachlorodibenzo-p-dioxin mechanistic data and risk assessment: gene regulation, cytotoxicity, enhanced cell proliferation, and tumor promotion Pharmacol. Ther. 71 1996 193 223
377. H.P. Shu, D.J. Paustenbach, and F.J. Murray A critical evaluation of the use of mutagenesis, carcinogenesis, and tumor promotion data in a cancer risk assessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin Regular Toxicol. Pharmacol. 7 1987 57 88
378. D. Gunz, S.E. Shephard, and W.K. Lutz Can nongenotoxic carcinogens be detected with the lacI transgenic mouse mutation assay? Environ. Mol. Mutagen. 21 1993 209 211
379. Carbon tetrachloride, International Programme on Chemical Safety, Geneva, World Health Organization, Environmental Health Criteria, 1999.
380. E.K. Weisburger Carcinogenicity studies on halogenated hydrocarbons Environ. Health Perspect. 21 1977 7 16
381. M.D. Reuber, and E.L. Glover Cirrhosis and carcinoma of the liver in male rats given subcutaneous carbon tetrachloride J. Natl. Cancer Inst. 44 1970 419 427
382. D. McGregor, and M. Lang Carbon tetrachloride: genetic effects and other modes of action Mutat. Res. 366 1996 181 195
383. International Agency for Research on Cancer, Carbon tetrachloride, IARC Monogr. Eval. Carcinog. Risks Hum. 71 Pt. 2 (1999) 401-432.
384. M. Tafazoli, A. Baeten, P. Geerlings, and M. Kirsch-Volders In vitro mutagenicity and genotoxicity study of a number of short-chain chlorinated hydrocarbons using the micronucleus test and the alkaline single cell gel electrophoresis technique (Comet assay) in human lymphocytes: a structure-activity relationship (QSAR) analysis of the genotoxic and cytotoxic potential Mutagenesis 13 1998 115 126
385. National Toxicology Program, NTP Toxicology and Carcinogenesis Studies of Nickel Subsulfide (CAS No. 12035-72-2) in F344 Rats and B6C3F1 Mice (Inhalation Studies), Natl. Toxicol. Program Tech. Rep. Ser. 453 (1996) 1-365.
386. Nickel, International Programme on Chemical Safety, Geneva, World Health Organization, Environmental Health Criteria Monographs, 1991.
387. 2 Mutagenesis 5 1990 583 589
388. S. Kawanishi, S. Oikawa, S. Inoue, and K. Nishino Distinct mechanisms of oxidative DNA damage induced by carcinogenic nickel subsulfide and nickel oxides Environ. Health Perspect. 110 Suppl. 5 2002 789 791
389. Y.W. Lee, C.B. Klein, B. Kargacin, K. Salnikow, J. Kitahara, K. Dowjat, A. Zhitkovich, N.T. Christie, and M. Costa Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens Mol. Cell. Biol. 15 1995 2547 2557
390. National Toxicology Program, Carcinogenesis Bioassay of Di(2-ethylhexyl)phthalate (CAS No. 117-81-7) in F344 Rats and B6C3F1 Mice (feed studies), Natl. Toxicol. Program Tech. Rep. Ser. 217 (1982) 1-127.
391. R.C. Cattley, J.G. Conway, and J.A. Popp Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years Cancer Lett. 38 1987 15 22
392. M.S. Rao, A.V. Yeldandi, and V. Subbarao Quantitative analysis of hepatocellular lesions induced by di(2-ethylhexyl)phthalate in F-344 rats J. Toxicol. Environ. Health 30 1990 85 89
393. P. Schmezer, B.L. Pool, R.G. Klein, D. Komitowski, and D. Schmahl Various short-term assays and two long-term studies with the plasticizer di(2-ethylhexyl)phthalate in the Syrian golden hamster Carcinogenesis 9 1988 37 43
394. R.L. Melnick Does chemically induced hepatocyte proliferation predict liver carcinogenesis? FASEB J. 6 1992 2698 2706
395. Diethylhexyl phthalate, International Programme on Chemical Safety, World Health Organization, Geneva, Environmental Health Criteria, 1992.
396. J. Doull, R. Cattley, C. Elcombe, B.G. Lake, J. Swenberg, C. Wilkinson, G. Williams, and M. van Gemert A cancer risk assessment of di(2-ethylhexyl) phthalate: application of the new US, EPA Risk Assessment Guidelines Regular Toxicol. Pharmacol. 29 1999 327 357
397. Carcinogenesis bioassay of chloroform, National Cancer Institute, NTIS No. PB264018/AS, National Cancer Institute, Bethesda, MD, 1976.
398. T.A. Jorgenson, E.F. Meierhenry, C.J. Rushbrook, R.J. Bull, and M. Robinson Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice Fundam. Appl. Toxicol. 5 1985 760 769
399. C.F. Tumasonis, D.N. McMartin, and B. Bush Lifetime toxicity of chloroform and bromodichloromethane when administered over a lifetime in rats Ecotoxicol. Environ. Saf. 9 1985 233 240
400. R.J. Golden, S.E. Holm, D.E. Robinson, P.H. Julkunen, and E.A. Reese Chloroform mode of action: implications for cancer risk assessment Regular Toxicol. Pharmacol. 26 1997 142 155
401. L. Robbiano, E. Mereto, A. Migliazzi Morando, P. Pastore, and G. Brambilla Increased frequency of micronucleated kidney cells in rats exposed to halogenated anaesthetics Mutat. Res. 413 1998 1 6
402. K. Fujie, T. Aoki, and M. Wada Acute and subacute cytogenetic effects of the trihalomethanes on rat bone marrow cells in vivo Mutat. Res. 242 1990 111 119
403. J.C. Mirsalis, C.K. Tyson, K.L. Steinmetz, E.K. Loh, C.M. Hamilton, J.P. Bakke, and J.W. Spalding Measurement of unscheduled DNA synthesis and S-phase synthesis in rodent hepatocytes following in vivo treatment: testing of 24 compounds Environ. Mol. Mutagen. 14 1989 155 164
404. Methyl bromide, International Programme on Chemical Safety, World Health Organization, Environmental Health Criteria, Geneva, 1995.
405. G.A. Boorman, H.L. Hong, C.W. Jameson, K. Yoshitomi, and R.R. Maronpot Regression of methyl bromide-induced forestomach lesions in the rat Toxicol. Appl. Pharmacol. 86 1986 131 139
406. K. Mitsumori, K. Maita, T. Kosaka, T. Miyaoka, and Y. Shirasu Two-year oral chronic toxicity and carcinogenicity study in rats of diets fumigated with methyl bromide Food Chem. Toxicol. 28 1990 109 119
407. National Toxicology Program, NTP toxicology and carcinogenesis studies of methyl bromide (CAS: 74-83-9) in B6C3F1 mice (inhalation studies), Natl. Toxicol. Program Tech. Rep. Ser. 385 (1992) 1-212.
408. P.G. Reuzel, H.C. Dreef-van der Meulen, V.M. Hollanders, C.F. Kuper, V.J. Feron, and C.A. van der Heijden Chronic inhalation toxicity and carcinogenicity study of methyl bromide in Wistar rats Food Chem. Toxicol. 29 1991 31 39
409. International Agency for Research on Cancer, Methyl bromide, IARC Monogr. Eval. Carcinog. Risks Hum. 71 Pt. 2 (1999) 721-735.
410. H.M. Bolt, and B. Gansewendt Mechanisms of carcinogenicity of methyl halides Crit. Rev. Toxicol. 23 1993 237 253
411. National Cancer Institute, Carcinogenesis bioassay of trichloroethylene, Natl. Cancer Inst. Carcinog. Tech. Rep. Ser. 2 (1976) 1-215.
412. National Toxicology Program, NTP carcinogenesis studies of trichloroethylene (without epichlorohydrin) (CAS No. 79-01-6) in F344/N rats and B6C3F1 mice (gavage studies), Natl. Toxicol. Program Tech. Rep. Ser. 243 (1990) 1-174.
413. R. Fahrig, S. Madle, and H. Baumann Genetic toxicology of trichloroethylene (TCE) Mutat. Res. 340 1995 1 36
414. M.M. Moore, and K. Harrington-Brock Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene Environ. Health Perspect. 108 Suppl 2 2000 215 223
415. National Toxicology Program, NTP toxicology and carcinogenesis studies of oxazepam (CAS No. 604-75-1) in SWISS-WEBster and B6C3F1 mice (feed studies), Natl. Toxicol. Program Tech. Rep. Ser. 443 (1993) 1-321.
416. National Toxicology Program, NTP toxicology and carcinogenesis studies of oxazepam (CAS No. 604-75-1) in F344/N rats (feed studies), Natl. Toxicol. Program Tech. Rep. Ser. 468 (1998) 1-189.
417. A.K. Giri, and S. Banerjee Genetic toxicology of four commonly used benzodiazepines: a review Mutat. Res. 340 1996 93 108
418. J.H. Bielas, and J.A. Heddle From the cover: proliferation is necessary for both repair and mutation in transgenic mouse cells (in process citation) Proc. Natl. Acad. Sci. U.S.A. 97 2000 11391 11396
419. L. Recio, and T.L. Goldsworthy The use of transgenic mice for studying mutagenicity induced by 1,3-butadiene Toxicol. Lett. 82-83 1995 607 612
420. S. Takahashi, S. Inaguma, Y.M. Cho, K. Imaida, J. Wang, O. Fujiwara, and T. Shirai Lack of mutation induction with exposure to 1.5 GHz electromagnetic near fields used for cellular phones in brains of Big Blue mice Cancer Res. 62 2002 1956 1960
421. T.M. Brooks, M. Szegedi, P. Rosher, and S.W. Dean The detection of gene mutation in transgenic mice (Muta™ mouse) following a single oral dose of 2-acetylaminofluorene Mutagenesis 10 1995 149 150
422. J.A. Ross, and S.A. Leavitt Induction of mutations by 2-acetylaminofluorene in lacI transgenic B6C3F1 mouse liver Mutagenesis 13 1998 173 179
423. S.E. Shephard, C. Sengstag, W.K. Lutz, and C. Schlatter Mutations in liver DNA of lacI transgenic mice (Big Blue) following subchronic exposure to 2-acetylaminofluorene Mutat. Res. 302 1993 91 96
424. M.M. von Pressentin, W. Kosinska, and J.B. Guttenplan Mutagenesis induced by oral carcinogens in lacZ mouse (Muta™ mouse) tongue and other oral tissues Carcinogenesis 20 1999 2167 2170
425. M.M. von Pressentin, K. El Bayoumy, and J.B. Guttenplan Mutagenic activity of 4-nitroquinoline-N-oxide in upper aerodigestive tissue in lacZ mice (Muta™ mouse) and the effects of 1,4-phenylenebis(methylene)selenocyanate Mutat. Res. 466 2000 71 78
426. K. Fletcher, A.R. Soames, H. Tinwell, P.A. Lefevre, and J. Ashby Hepatic gene mutations induced in Big Blue rats by both the potent rat liver azo-carcinogen 6BT and its reported noncarcinogenic analogue 5BT Environ. Mol. Mutagen. 34 1999 148 153
427. P.A. Lefevre, H. Tinwell, and J. Ashby Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol Mutagenesis 12 1997 45 47
428. R.A. Mittelstaedt, M.G. Manjanatha, S.D. Shelton, L.E. Lyn-Cook, J.B. Chen, A. Aidoo, D.A. Casciano, and R.H. Heflich Comparison of the types of mutations induced by 7,12-dimethylbenz[a]anthracene in the lacI and hprt genes of Big Blue rats Environ. Mol. Mutagen. 31 1998 149 156
429. M.G. Manjanatha, S.D. Shelton, S.J. Culp, L.R. Blankenship, and D.A. Casciano DNA adduct formation and molecular analysis of in vivo lacI mutations in the mammary tissue of Big Blue rats treated with 7, 12-dimethylbenz[a] anthracene Carcinogenesis 21 2000 265 273
430. P. Quillardet, V. Michel, X. Arrault, M. Hofnung, and E. Touati Mutagenic properties of a nitrofuran, 7-methoxy-2-nitronaphtho[2,1-b]furan (R7000), in lacI transgenic mice (in process citation) Mutat. Res. 470 2000 177 188
431. L. Crawford, and B. Myhr A preliminary assessment of the toxic and mutagenic potential of steroidal alkaloids in transgenic mice Food Chem. Toxicol. 33 1995 191 194
432. I.N. White, P. Carthew, R. Davies, J. Styles, K. Brown, J.E. Brown, L.L. Smith, and E.A. Martin Short-term dosing of alpha-hydroxytamoxifen results in DNA damage but does not lead to liver tumours in female Wistar/Han rats Carcinogenesis 22 2001 553 557
433. G.G. da Costa, M.G. Manjanatha, M.M. Marques, and F.A. Beland Induction of lacI mutations in Big Blue rats treated with tamoxifen and alpha-hydroxytamoxifen Cancer Lett. 176 2002 37 45
434. W. Suter, A. Hartmann, F. Poetter, P. Sagelsdorff, P. Hoffmann, and H.J. Martus Genotoxicity assessment of the antiepileptic drug AMP397, an Ames-positive aromatic nitro compound Mutat. Res. 518 2002 181 194
435. T. Jiang, B.W. Glickman, and J.G. deBoer Protective effect of green tea against benzo[a]pyrene-induced mutations in the liver of Big Blue transgenic mice Mutat Res. 480-481 2001 147 151
436. K. Unfried, C. Schurkes, and J. Abel Distinct spectrum of mutations induced by crocidolite asbestos: clue for 8-hydroxydeoxyguanosine-dependent mutagenesis in vivo Cancer Res. 62 2002 99 104
437. B.S. Shane, A.M. Lockhart, G.W. Winston, and K.R. Tindall Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy Mutat. Res. 377 1997 1 11
438. M.E. Boerrigter, M.E. Dolle, H.J. Martus, J.A. Gossen, and J. Vijg Plasmid-based transgenic mouse model for studying in vivo mutations Nature 377 1995 657 659
439. J.M. Gentile, G.J. Gentile, B. Nannenga, M. Johnson, H. Blankespoor, and R. Montero Enhanced liver cell mutations in trematode-infected Big Blue transgenic mice Mutat. Res. 400 1998 355 360
440. G.A. Trentin, J. Moody, and J.A. Heddle Effect of maternal folate levels on somatic mutation frequency in the developing colon Mutat. Res. 405 1998 81 87
441. R.A. Winegar, L.H. Lutze, J.D. Hamer, K.G. O'Loughlin, and J.C. Mirsalis Radiation-induced point mutations, deletions and micronuclei in lacI transgenic mice Mutat. Res. 307 1994 479 487
442. G.A. Luke, A.C. Riches, and P.E. Bryant Genomic instability in haematopoietic cells of F1 generation mice of irradiated male parents Mutagenesis 12 1997 147 152
443. S. Itoh, and H. Shimada Bone marrow and liver mutagenesis in lacZ transgenic mice treated with hexavalent chromium Mutat. Res. 412 1998 63 67
444. L. Cheng, S. Liu, and K. Dixon Analysis of repair and mutagenesis of chromium-induced DNA damage in yeast, mammalian cells, and transgenic mice Environ. Health Perspect. 106 Suppl. 4 1998 1027 1032
445. S. Itoh, and H. Shimada Clastogenicity and mutagenicity of hexavalent chromium in lacZ transgenic mice Toxicol. Lett. 91 1997 229 233
446. H.J. Martus, M. Novak, D. Blecher, A. Duyn-Goedhart, W. Suter, J.A. Gossen, and P.P. van Buul Quantitative correlation between radiation-induced mutagenesis in endogenous genes and transgenes of mouse spermatogonial stem cells Environ. Mol. Mutagen. 34 1999 216 220
447. A.T. Lee, D. Reis, and U.J. Eriksson Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo Diabetes 48 1999 371 376
448. D.L. Putman, A.P. Ritter, G.J. Carr, and R.R. Young Evaluation of spontaneous and chemical-induced lacI mutations in germ cells from lambda/lacI transgenic mice Mutat. Res. 388 1997 137 143
449. M. Katoh, T. Inomata, N. Horiya, F. Suzuki, T. Shida, K. Ishioka, and T. Shibuya Studies on mutations in male germ cells of transgenic mice following exposure to isopropyl methanesulfonate, ethylnitrosourea or X-ray Mutat. Res. 341 1994 17 28
450. G.S. Provost, B.J. Rogers, M.J. Dycaico, and G. Carr Evaluation of the transgenic Lambda/LacI mouse model as a short-term predictor of heritable risk Mutat. Res. 388 1997 129 136
451. N.J. Gorelick, J.L. Andrews, D.P. Gibson, G.J. Carr, and M.J. Aardema
452. G.R. Douglas, J.D. Gingerich, L.M. Soper, and J. Jiao Toward an understanding of the use of transgenic mice for the detection of gene mutations in germ cells Mutat. Res. 388 1997 197 212
453. U.M. Liegibel, and P. Schmezer Detection of the two germ cell mutagens ENU and iPMS using the LacZ/transgenic mouse mutation assay Mutat. Res. 388 1997 213 218
454. R.A. Winegar, G. Carr, and J.C. Mirsalis Analysis of the mutagenic potential of ENU and MMS in germ cells of male C57BL/6 lacI transgenic mice Mutat. Res. 388 1997 175 178
455. T. Suzuki, S. Itoh, N. Takemoto, N. Yajima, M. Miura, M. Hayashi, H. Shimada, and T. Sofuni Ethyl nitrosourea and methyl methanesulfonate mutagenicity in sperm and testicular germ cells of lacZ transgenic mice (Muta™ mouse) Mutat. Res. 388 1997 155 163
456. S. Itoh, M. Miura, and H. Shimada Germ cell mutagenesis in lacZ transgenic mice treated with methyl methanesulfonate Mutat. Res. 388 1997 223 228
457. B. Sun, N. Shima, and J.A. Heddle Somatic mutation in the mammary gland: influence of time and estrus Mutat. Res. 427 1999 11 19
458. G.S. Provost, and J.M. Short Characterization of mutations induced by ethylnitrosourea in seminiferous tubule germ cells of transgenic B6C3F1 mice Proc. Natl. Acad. Sci. U.S.A. 91 1994 6564 6568
459. T. Hara, H. Sui, K. Kawakami, Y. Shimada, and T. Shibuya Partial hepatectomy strongly increased the mutagenicity of N-ethyl-N-nitrosourea in Muta™ mouse liver Environ. Mol. Mutagen. 34 1999 121 123
460. M. Katoh, N. Horiya, and R.P. Valdivia Mutations induced in male germ cells after treatment of transgenic mice with ethylnitrosourea Mutat. Res. 388 1997 229 237
461. W. Cruz-Munoz, W. Kalair, L. Cosentino, and J.A. Heddle ENU induces mutations in the heart of lacZ transgenic mice (in process citation) Mutat. Res. 469 2000 23 34
462. V. Morrison, H. Tinwell, and J. Ashby Consideration of the liver of embryonic lacZ transgenic mice as an analogue of the mouse coat colour spot test: preliminary data and technical problems Mutat. Res. 329 1995 107 112
463. E. Allay, M. Veigl, and S.L. Gerson Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea Oncogene 18 1999 3783 3787
464. S. Zhang, R. Lloyd, G. Bowden, B.W. Glickman, and J.G. deBoer Msh2 DNA mismatch repair gene deficiency and the food-borne mutagen 2-amino-1-methy1-6- phenolimidazo[4,5-b] pyridine (PhIP) synergistically affect mutagenesis in mouse colon Oncogene 20 2001 6066 6072
465. G.R. Stuart, J. Holcroft, J.G. deBoer, and B.W. Glickman Prostate mutations in rats induced by the suspected human carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine Cancer Res. 60 2000 266 268
466. T. Suzuki, Y. Uno, K. Idehara, T. Baba, J. Maniwa, A. Ohkouchi, X. Wang, M. Hayashi, T. Sofuni, M. Tsuruoka, H. Miyajima, and K. Kondo Procarbazine genotoxicity in the Muta™ mouse; strong clastogenicity and organ-specific induction of lacZ mutations Mutat. Res. 444 1999 269 281
467. P. Schmezer, C. Eckert, and U.M. Liegibel Tissue-specific induction of mutations by streptozotocin in vivo Mutat. Res. 307 1994 495 499
468. J.G. deBoer, J. Holcroft, M.L. Cunningham, and B.W. Glickman Tris(2,3-dibromopropyl)phosphate causes a gradient of mutations in the cortex and outer and inner medullas of the kidney of lacI transgenic rats Environ. Mol. Mutagen. 36 2000 1 4
469. C.V. Williams, K. Fletcher, H. Tinwell, and J. Ashby Mutagenicity of ethyl carbamate to lacZ- transgenic mice Mutagenesis 13 1998 133 137
470. H. Ikehata, S. Aiba, H. Ozawa, and T. Ono Thermolysin improves mutation analysis in skin epidermis from ultraviolet light-irradiated Muta™Mouse Environ. Mol. Mutagen. 38 2001 55 58
471. T. Ono, H. Ikehata, Y. Hosoi, B.S. Shung, A. Kurishita, X. Wang, K. Yamamoto, T. Suzuki, and T. Sofuni X-ray- and ultraviolet-radiation-induced mutations in Muta™ mouse Radiat. Res. 148 1997 123 128
472. G.R. Stuart, N.J. Gorelick, J.L. Andrews, J.G. deBoer, and B.W. Glickman The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice Environ. Mol. Mutagen. 28 1996 385 392
473. J.A. Kind, R.N. Winn, M.E. Boerrigter, C.H. Jagoe, T.C. Glenn, and C.E. Dallas Investigation of the radioadaptive response in brain and liver of pUR288 lacZ transgenic mice J. Toxicol. Environ. Health A 63 2001 207 220
474. A.N. Tutt, C.T. van Oostrom, G.M. Ross, H. van Steeg, and A. Ashworth Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation EMBO Rep. 2002 255 260